Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2024

☐	TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission File Number: 000-53832

RANGE IMPACT, INC.

(Exact name of registrant as specified in its charter)

Nevada

75-3268988

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

200 Park Avenue, Suite 400
Cleveland, OH		44122
(Address of principal executive offices)		(Zip Code)

(216) 304-6556

Registrant’s telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:		Trading Symbol		Name of each exchange on which registered:
Common Stock		RNGE		OTC Markets

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

As of August 13, 2024, there were 104,727,189 shares of the registrant’s common stock, $0.001 par value per share, outstanding.

RANGE IMPACT, INC.

Quarterly Report on Form 10-Q

For the Quarterly Period Ended

June 30, 2024

INDEX

PART I - FINANCIAL INFORMATION	3

Item 1. Financial Statements (unaudited)	3
Consolidated Unaudited Balance Sheets as of June 30, 2024 and December 31, 2023	4
Consolidated Unaudited Statements of Operations for the Three and Six Months Ended June 30, 2024 and June 30, 2023	5
Consolidated Unaudited Statements of Changes in Stockholders’ Equity (Deficit) for the Three and Six Months Ended June 30, 2024 and June 30, 2023	6
Consolidated Unaudited Statements of Cash Flows for the Six Months Ended June 30, 2024 and June 30, 2023	7
Notes to the Consolidated Unaudited Financial Statements	8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
Item 3. Quantitative and Qualitative Disclosures About Market Risk	29
Item 4. Controls and Procedures	29

PART II - OTHER INFORMATION	30

Item 1. Legal Proceedings	30
Item 1A. Risk Factors	30
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	30
Item 6. Exhibits	30

SIGNATURES	31

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)

RANGE IMPACT, INC.

CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

CONSOLIDATED UNAUDITED BALANCE SHEETS AS OF JUNE 30, 2024 AND DECEMBER 31, 2023	4

CONSOLIDATED UNAUDITED STATEMENTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2024 AND JUNE 30, 2023	5

CONSOLIDATED UNAUDITED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2024 AND JUNE 30, 2023	6

CONSOLIDATED UNAUDITED STATEMENTS OF CASH FLOWS FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND JUNE 30, 2023	7

NOTES TO THE CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS	8

RANGE IMPACT, INC.

CONSOLIDATED BALANCE SHEETS

	June 30, 2024 (unaudited)			December 31, 2023
Assets

Current Assets
Cash and cash equivalents	$	123,713		$	2,176,800
Accounts receivable		4,388,785			7,185,411
Contract assets		1,374,962			247,310
Inventory		725,429			-
Prepaid expenses		42,204			115,324
Total current assets		6,655,093			9,724,845
Long-term Assets
Property and equipment, net of accumulated depreciation		12,025,030			13,301,902
Goodwill		751,421			751,421
Deposits		9,976			9,976
Total long-term assets		12,786,427			14,063,299
Total Assets	$	19,441,520		$	23,788,144

Liabilities and Stockholders’ Equity

Current Liabilities
Accounts payable	$	2,036,868		$	3,714,014
Line of credit		2,200,000			2,400,000
Current portion of long-term debt		2,617,444			2,755,792
Deposits		150,000			-
Accrued expenses		54,402			101,283
Total current liabilities		7,058,714			8,971,089
Long-term Liabilities
Long-term debt, net of current portion		4,198,819			5,250,027
Total long-term debt		4,198,819			5,250,027
Total liabilities		11,257,533			14,221,116

Stockholders’ Equity
Common stock, par value $0.001 per share; 1,000,000,000 shares authorized; 104,727,189 and 101,023,485 shares issued and outstanding, respectively		104,727			101,023
Additional paid-in-capital		57,600,580			56,547,804
Accumulated deficit		(49,521,320	)		(47,081,799	)
Total stockholders’ equity		8,183,987			9,567,028
Total Liabilities and Stockholders’ Equity	$	19,441,520		$	23,788,144

See accompanying notes to the consolidated financial statements.

RANGE IMPACT, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	2024			2023			2024			2023
	Three Months Ended June 30,						Six Months Ended June 30,
	2024			2023			2024			2023

Revenues	$	2,349,738		$	3,998,267		$	6,259,631		$	7,013,154
Cost of services		2,498,667			3,153,166			6,389,706			5,519,051
Gross profit (loss)		(148,929	)		845,101			(130,075	)		1,494,103

Operating expenses:
General and administrative		697,699			635,898			1,641,600			1,361,946
Research and development		157,278			107,444			288,918			213,621
Total operating expenses		854,977			743,342			1,930,518			1,575,567

Profit (loss) from operations		(1,003,906	)		101,759			(2,060,593	)		(81,464	)

Other income (expense):
Other income		485			-			18,590
Interest expense		(165,660	)		(64,997	)		(340,918	)		(108,634	)
Total other income (expense)		(165,175	)		(64,997	)		(322,328	)		(108,634	)

Income tax expense		56,600						56,600
Net loss	$	(1,225,681	)	$	36,762		$	(2,439,521	)	$	(190,098	)

Net loss per share – basic and diluted	$	(0.01	)	$	0.00		$	(0.02	)	$	(0.00	)
Weighted average number of common shares outstanding – basic and diluted		101,552,586			80,519,745			101,288,035			79,324,917

See accompanying notes to the consolidated financial statements.

RANGE IMPACT, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

	Number of Shares		Amount		Paid-in Capital		Accumulated Deficit			Total
	Three Months Ended June 30, 2024
	Common Stock				Additional
	Number of Shares		Amount		Paid-in Capital		Accumulated Deficit			Total
Balance as of March 31, 2024		101,023,485	$	101,023	$	56,552,294	$	(48,295,639	)	$	8,357,678
Shares issued for cash		3,703,704		3,704		996,296		-			1,000,000
Stock based compensation		-		-		51,990		-			51,990
Net loss		-		-		-		(1,225,681	)		(1,225,681	)
Balance as of June 30, 2024		104,727,189	$	104,727	$	57,600,580	$	(49,521,320	)	$	8,183,987

	Three Months Ended June 30, 2023
	Common Stock				Additional
	Number of Shares		Amount		Paid-in Capital		Accumulated Deficit			Total
Balance as of March 31, 2023		78,116,814	$	78,117	$	53,074,180	$	(50,439,714	)	$	2,712,583
Shares issued for cash		2,733,334		2,733		407,267		-			410,000
Fair value of vested stock options		-		-		35,920		-			35,920
Net income		-		-		-		36,762			36,762
Balance as of June 30, 2023		80,850,148	$	80,850	$	53,517,367	$	(50,402,952	)	$	3,195,265

	Six Months Ended June 30, 2024
	Common Stock				Additional
	Number of Shares		Amount		Paid-in Capital		Accumulated Deficit			Total
Balance as of December 31, 2023		101,023,485	$	101,023	$	56,547,804	$	(47,081,799	)	$	9,567,028
Shares issued for cash		3,703,704		3,704		996,296		-			1,000,000
Stock based compensation		-		-		56,480		-			56,480
Net loss		-		-		-		(2,439,521	)		(2,439,521	)
Balance as of June 30, 2024		104,727,189	$	104,727	$	57,600,580	$	(49,521,320	)	$	8,183,987

	Six Months Ended June 30, 2023
	Common Stock				Additional
	Number of Shares		Amount		Paid-in Capital		Accumulated Deficit			Total
Balance as of December 31, 2022		78,116,814	$	78,117	$	53,074,180	$	(50,212,854	)	$	2,939,443
Balance		78,116,814	$	78,117	$	53,074,180	$	(50,212,854	)	$	2,939,443
Shares issued for cash		2,733,334		2,733		407,267		-			410,000
Fair value of vested stock options		-		-		35,920		-			35,920
Net loss		-		-		-		(190,098	)		(190,098	)
Net income (loss)		-		-		-		(190,098	)		(190,098	)
Balance as of June 30, 2023		80,850,148	$	80,850	$	53,517,367	$	(50,402,952	)	$	3,195,265
Balance		80,850,148	$	80,850	$	53,517,367	$	(50,402,952	)	$	3,195,265

See accompanying notes to the consolidated financial statements.

RANGE IMPACT, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	2024			2023
	Six Months Ended June 30,
	2024			2023
Cash flows from operating activities:
Net loss	$	(2,439,521	)	$	(190,098	)

Adjustments to reconcile net loss to net cash (used in) operating activities:
Fair value of vested stock options		56,480			35,920
Depreciation		1,276,872			695,910
Changes in operating assets and liabilities:
Accounts receivable		2,796,626			(1,421,296	)
Contract assets		(1,127,652	)		-
Inventory		(725,429	)		-
Prepaid expenses and other current assets		73,121			(46,835	)
Accounts payable		(1,677,147	)		539,084
Deposits		150,000
Accrued expenses		(46,881	)		-
Deposits		-			(11,084	)
Net cash (used in) operating activities		(1,663,531	)		(398,399	)

Cash flows from investing activities:
Equipment purchases		-			(784,515	)
Net cash provided by (used in) investing activities		-			(784,515	)

Cash flows from financing activities:
Issuance of shares for cash		1,000,000			410,000
Proceeds from long-term debt		-			383,202
Repayment of long-term debt		(1,189,556	)		(893,093	)
Proceeds from (repayment of) line of credit		(200,000	)		1,200,000
Net cash provided by (used in) financing activities		(389,556	)		1,100,109

Net decrease in cash and cash equivalents		(2,053,087	)		(82,805	)

Cash and cash equivalents - beginning of period		2,176,800			442,369
Cash and cash equivalents - end of period	$	123,713		$	359,564

Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest	$	251,348		$	108,634

See accompanying notes to the consolidated financial statements.

RANGE IMPACT, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

THREE AND SIX MONTHS ENDED JUNE 30, 2024 AND 2023

(Unaudited)

1. BUSINESS OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Range Impact, Inc. (the “Company”, “we”, “us”, or “our”), was incorporated in the State of Nevada on June 29, 2007.

Originally founded in 2007 as Legend Mining Inc., the Company began operations as a mineral extraction exploration business. In 2011, the Company changed its name to Stevia First Corp and pursued a new strategy focused on developing stevia-based additives for the food and beverage industry. In 2015, the Company changed its name to Vitality Biopharma, Inc. and pursued a new strategy focused on developing cannabinoid-based prodrugs anticipated to treat inflammatory conditions of the gastrointestinal tract.

In October 2021, the Company changed its name to Malachite Innovations, Inc. and formed two wholly-owned operating subsidiaries: (i) Graphium Biosciences, Inc., a Nevada corporation (“Graphium”), into which the Company contributed all of its drug development assets; and (ii) Daedalus Ecosciences, Inc., a Nevada corporation (“Daedalus”), which was formed to serve as a holding company for the Company’s future impact investing businesses.

In May 2022, Daedalus acquired Range Environmental Resources, Inc., a West Virginia corporation (“Range Environmental”) and Range Natural Resources, Inc., a West Virginia corporation (“Range Natural” and together with Range Environmental, the “Range Reclamation Entities”). The Range Reclamation Entities provide land reclamation and water restoration services to mining and non-mining customers throughout the Appalachian region with the goal of returning land to pre-mining conditions or repurposing the land for natural, commercial, agricultural or recreational use. The Range Reclamation Entities’ water restoration services seek to improve the water quality in rivers, streams and discharges through novel and innovative treatment applications to help customers meet their various regulatory standards and requirements. Range Natural also engages subcontractors who control and are responsible for the mining and selling of coal to third-party customers incidental to the reclamation and repurposing of mine sites.

In August 2023, the Company acquired Collins Building & Contracting, Inc., a West Virginia corporation (“Collins Building”), an environmental services business primarily focusing on the reclamation of abandoned mine land sites in West Virginia, as described in more detail in Note 2.

In December 2023, the Company changed its name to Range Impact, Inc., and reorganized into five operating business segments: (i) Range Reclaim; (ii) Range Water; (iii) Range Security; (iv) Range Land; and (v) Drug Development.

In January 2024, the Company added Range Minerals as its sixth operating business segment. Range Minerals was previously reported within the Range Reclaim operating business segment. The Drug Development segment was also renamed Graphium Biosciences.

Basis of Presentation

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries: CLV Azurite Land LLC, Collins Building & Contracting, Inc., Graphium Biosciences, Inc., Range Environmental Resources, Inc., Range Land, LLC, Range Minerals, LLC, Range Natural Resources, Inc., Range Reclaim, LLC, Range Security, LLC, Range Security Resources, LLC, Range Water, LLC, Terra Preta, LLC, Aether Credit Ventures, Inc. (dissolved in November 2023), Pristine Stream Ventures, Inc. (dissolved in November 2023), NextGen AgriTech, Inc. (dissolved in November 2023), and Daedalus Ecosciences, Inc. (merged into Range Impact, Inc. in December 2022), and have been prepared in accordance with accounting principles generally accepted in the United States of America. Intercompany balances and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

Business Combinations

Business combinations are accounted for using the purchase method of accounting under ASC 805, “Business Combinations.” This method requires the Company to record assets and liabilities of the businesses acquired at their estimated fair values as of the acquisition date. Any excess of the cost of the acquisition over the fair value of the net assets acquired is recorded as goodwill. Any excess of the fair value of the net assets acquired over the cost of the acquisition is accounted for as a bargain purchase gain. Determining the fair value requires management to make estimates and assumptions including discount rates, rates of return on assets, and long-term sales growth rates.

Revenue Recognition

The Company recognizes revenue under ASC 606, “Revenue from Contracts with Customers”. The core principle of the ASC 606 revenue standard is that a company should recognize revenue by analyzing the following five steps: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) each performance obligation is satisfied.

The Company primarily invoices customers and recognizes revenue on a periodic basis for equipment and labor hours provided to a customer on a particular job based on an agreed-upon hourly rate sheet or a fixed amount for a project. The Company also invoices customers and recognizes revenue for equipment mobilization fees and materials and supplies required to complete a project. The Company invoices for the sales of chemicals, stone and other products and recognizes revenue when the products are delivered to the customer’s designated site or when control of these products is transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. Sales taxes and other taxes that the Company collects concurrent with revenue producing activities are excluded from revenue. Costs for equipment, labor and chemicals are generally expensed as incurred since the projects are generally short-term and not subject to a contract. The Company also invoices customers for the provision of environmental security services at an agreed-upon hourly rate for each project. All revenue is recognized at a point in time.

The Company recognizes revenue on reclamation contracts over time as performance obligations are satisfied due to the continuous transfer of control to the customer. The Company’s contracts are generally accounted for as a single performance obligation since the Company is providing a significant service of integrating components into a single project. The Company recognizes revenue using a cost-based input method by which actual costs incurred relative to total estimated contract costs determine, as a percentage, progress toward contract completion. This percentage is applied to the contract price to determine the amount of revenue to recognize. The Company believes the cost-based input method is the most faithful depiction of performance because it directly measures the value of the services transferred to the customer.

Contract Estimates

Due to the nature of the Company’s performance obligations, the estimation of total revenue and cost at completion is subject to many variables and requires significant judgment. Since a significant change in one or more of these variables could affect the profitability of contracts, the Company reviews and updates contract-related estimates regularly through a review process in which the Company reviews the progress and execution of performance obligations and the estimated cost at completion.

The Company recognizes adjustments in estimated profit on contracts under the cumulative catch-up method. Under this method, the impact of the adjustment on profit recorded to date is recognized in the period the adjustment is identified. Revenue and profit in future periods of contract performance is recognized using the adjusted estimate. If at any time the estimate of contract profitability indicates an anticipated loss on the contract, a provision for the entire loss is recognized in the period it is identified.

Contract Modifications

Contract modifications can occur during the performance of the Company’s contracts. Contracts may be modified to account for changes in contract specifications or requirements. In most instances, contract modifications are for goods or services that are not distinct, and, therefore, are accounted for as part of the existing contract.

Cost and Expense Recognition

Contract costs include all direct labor, materials, equipment mobilization, subcontractor, and equipment costs, and those indirect costs related to contract performance, such as indirect labor, tools and supplies. Costs are recognized as incurred.

The Company recognizes revenue from contracts for financial reporting purposes over time. Progress toward completion of the Company’s contracts is measured by the percentage of cost incurred to date compared to estimated total costs for each contract. This method is used because management considers total cost to be the best available measure of progress on contracts. Because of inherent uncertainties in estimating costs, it is at least reasonably possible that the estimates used will change significantly over the course of the contract’s performance.

Revenue earned over time compared to a point in time is as follows for the three and six months ended June 30, 2024 and 2023.

	Three Months Ended June 30, 2024		Three Months Ended June 30, 2023

Earned over time	$	1,179,341	$	-
Point in time		1,170,397		3,998,267
Total revenue		2,349,738		3,998,267

	Six Months Ended June 30, 2024		Six Months Ended June 30, 2023

Earned over time	$	2,049,835	$	-
Point in time		4,209,796		7,013,154
Total revenue		6,259,631		7,013,154

Cost of Services

Contract costs include all direct labor, materials, subcontractor, and equipment costs and those indirect costs related to contract performance, such as indirect labor, tools and supplies. For construction contracts, costs are generally recognized as incurred. Under certain circumstances, costs incurred in the period related to future activity on contracts may be capitalized.

Costs incurred that do not contribute to satisfying performance obligations are excluded from the cost input calculation for revenue recognition. Excluded costs include both uninstalled materials and abnormal costs. Abnormal costs comprise wasted materials, wasted or rework labor and other resources to fulfill a contract that were not reflected in the price of the contract. A limited allowance for material overages and labor inefficiencies is typically included in our contract costs estimates (and by extension, in the contract price).

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less at the date of acquisition to be cash equivalents. From time to time, the Company’s cash account balances exceed the balances covered by the Federal Deposit Insurance Corporation. The Company has never suffered a loss due to such excess balances.

Accounts Receivable

Included as a component of accounts receivable are contract receivables that represent the Company’s unconditional right, subject only to the passage of time, to receive consideration arising from performance obligations under reclamation contracts with customers. Billed contract receivables have been invoiced to customers based on contracted amounts. Contract receivables were $0 at June 30, 2024 and $2,100,255 as of December 31, 2023. Trade accounts receivable are stated at the amount management expects to collect from the balances outstanding as of June 30, 2024 or December 31, 2023 in the consolidated balance sheets. Based on management’s assessment, it has concluded that losses on balances outstanding as of those dates will be immaterial and therefore, no allowances were recorded for the six months ended June 31, 2024 or the six months ended June 30, 2023. Accounts receivable, including contract receivables, were $4,388,785 and $7,185,411 at June 30, 2024 and December 31, 2023, respectively. No credit loss expense was accrued in either the six months ended June 30, 2024 or the six months ended June 30, 2023 and there is no allowance for doubtful accounts as of June 30, 2024 or December 31, 2023.

Contract Assets

Billing practices are governed by the contract terms of each project based upon costs incurred, achievement of milestones or predetermined schedules. Billings do not necessarily correlate with revenue recognized over time using the percentage-of-completion method. Contract assets include unbilled amounts typically resulting from revenue under long-term contracts when the percentage-of-completion method of revenue recognition is utilized, and revenue recognition exceeds the amount billed to the customer. The Company’s contract assets are reported on a contract-by-contract basis at the end of each reporting period. The Company classifies contract assets as current or noncurrent based on whether the revenue is expected to be recognized sooner or later than one year from the balance sheet date.

Details of contract assets arising from reclamation contracts in process as of June 30, 2024 and December 31, 2023 are as follows:

SCHEDULE OF CONTRACT ASSETS

	June 30, 2024			December 31, 2023
Costs incurred on contracts in progress	$	1,623,680		$	425,634
Estimated earnings		1,192,317			340,528
Revenue earned on contracts in progress		2,815,997			766,162
Less: Billings to date		(1,441,035	)		(518,852	)
Total contract assets	$	1,374,962		$	247,310

Inventory

On May 1, 2024, Range Minerals (“Range Minerals”) contracted with a mining contractor (“Contractor”) at the Fola mining site in West Virginia. Contractor subcontracted the mining work to a subcontractor (“Subcontractor”). As of June 30, 2024, Contractor failed to perform. On June 30, 2024, Range Minerals agreed to assume the liability of $725,429 due from the Contractor to the Subcontractor in exchange for the ownership of the coal that had been mined by the Subcontractor. The inventory value of $725,429 is the cost of the inventory to the Contractor.

SCHEDULE OF INVENTORY

	June 30, 2024		December 31, 2023
Saleable coal inventory	$	725,429	$	-
Total coal inventory	$	725,429	$	-

Property & Equipment

Property and equipment is carried at cost. Expenditures for maintenance and repairs are charged to cost of services. Additions and betterments are capitalized. The cost and related accumulated depreciation of equipment sold or otherwise disposed of are removed from the accounts and any gain or loss is reflected in the current year’s earnings.

SCHEDULE OF PROPERTY AND EQUIPMENT

	June 30, 2024			December 31, 2023

Equipment	$	13,835,929		$	13,835,929
Land		1,563,797			1,563,797
Buildings		199,500			199,500
Property and equipment, gross
Accumulated depreciation		(3,574,196	)		(2,297,324	)
Net book value		12,025,030			13,301,902
Depreciation expense	$	1,276,872		$	1,781,573

The Company provides for depreciation of its buildings, property and equipment using the straight-line method for both financial reporting and federal income tax purposes over the estimated six-year useful lives of the assets.

The Company assesses the recoverability of its property and equipment by determining whether the depreciation of the assets over their remaining lives can be recovered through projected future cash flows generated by the assets. There were no assets identified for impairment.

Land

Land is carried at cost. The Company assesses the recoverability of its land by determining whether the cost of the land can be recovered through projected future cash flows generated by the land. No land was identified for impairment.

Delivery Costs

Delivery costs are classified as cost of sales.

Goodwill

U.S. GAAP requires that goodwill be tested for impairment annually and more frequently if events or changes in circumstances indicate that it is more likely than not (i.e., a likelihood greater than 50%) that the reporting unit is impaired. During interim periods, ASC 350 requires companies to focus on those events and circumstances that affect the significant inputs used to determine the fair value of the reporting unit to determine whether an interim quantitative impairment test is required.

The Company performed its quarterly impairment test for goodwill on June 30, 2024. The Company first assessed certain qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount, and whether it is therefore necessary to perform the quantitative impairment test. The qualitative analysis indicated that a quantitative impairment test was not necessary.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes. Under this method, deferred income tax assets and liabilities are recognized for the estimated tax consequences attributable to differences between the financial statement carrying values and their respective income tax basis (temporary differences). The effect on deferred income tax assets and liabilities of a change in tax rates is recognized as income (loss) in the period that includes the enactment date.

Leases

The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments. As of June 30, 2024, the Company had no material lease commitments for longer than one year.

Stock-Based Compensation

The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Consolidated Statements of Operations with classification depending on the nature of the services rendered.

The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

Basic and Diluted Income (Loss) Per Share

Basic income (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of outstanding common shares during the period. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted income (loss) per share is computed by dividing net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued. Diluted income (loss) per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive:

	June 30, 2024		December 31, 2023
Options		11,619,210		11,392,544
Warrants		3,313,335		3,313,335
Total		14,932,545		14,705,879
Anti-dilutive loss per share		14,932,545		14,705,879

Patents and Patent Application Costs

Although the Company believes that its patents and underlying technology have continuing value, the amount of future benefits to be derived from the patents is uncertain. Accordingly, patent costs are expensed as incurred.

Research and Development

Research and development costs consist primarily of fees paid to consultants and outside service providers, patent fees and costs, and other expenses relating to the acquisition, design, development and testing of the Company’s treatments and product candidates. Research and development costs are expensed as incurred.

Fair Value of Financial Instruments

FASB ASC 825, “Financial Instruments” requires that the Company disclose estimated fair values of financial instruments. Financial instruments held by the Company include, among others, accounts receivable, accounts payable and long-term debt. The carrying amounts reported in the balance sheets for assets and liabilities qualifying as financial instruments are a reasonable estimate of fair value.

Segments

As of June 30, 2024, the Company has six operating business segments: (i) Range Reclaim; (ii) Range Minerals; (iii) Range Water; (iv) Range Security; (v) Range Land; and (vi) Graphium Biosciences. Previously, beginning in October 2021, the Company began operating under two segments: (A) the Drug Development segment, which reports the operating results of the Company’s broad portfolio of glycosylated cannabinoid prodrugs operating under the name Graphium Biosciences, and (B) the Range Reclaim segment, which provides land reclamation, water restoration and incidental coal mining to customers throughout Appalachia. The Range Water, Range Security and Range Land business segments began operations in 2023. Beginning in January 2024, Range Minerals, which was previously reported within the Range Reclaim operating business segment, was separately reported as its own operating business segment focused on coal mining, using subcontractors, and related reclamation activities, and the Drug Development segment was renamed Graphium Biosciences.

In accordance with the “Segment Reporting” Topic of the ASC 280, the Company’s chief operating decision-maker has been identified as the Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing, and distribution processes.

Recent Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU enhances reportable segment disclosures on both an annual and interim basis primarily in regards to the disclosure of significant segment expenses that are regularly provided to the chief operating decision maker (CODM) and included within the reported measure(s) of segment profit or loss. In addition, the ASU requires disclosure, by segment, of other items included in the reported measure(s) of segment profit or loss, including qualitative information describing the composition, nature and type of each item. The ASU also expands disclosure requirements related to the CODM, including how the reported measure(s) of segment profit or loss are used to assess segment performance and allocate resources, and the method used to allocate overhead for significant segment expenses. All current required annual segment reporting disclosures under Topic 280 are now effective for interim periods. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the impact of adopting this ASU.

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU enhances income tax disclosures by providing information to better assess how an entity’s operations, related tax risks, tax planning and operational opportunities affect its tax rate and prospects for future cash flows. This ASU requires additional disclosures to the annual effective tax rate reconciliation including specific categories and further disaggregated reconciling items that meet the quantitative threshold. Additionally, the ASU requires disclosures relating to income tax expense and payments made to federal, state, local and foreign jurisdictions. This ASU is effective for fiscal years and interim periods beginning after December 15, 2024. The Company is evaluating the impact of adopting this ASU.

2. ACQUISITION OF COLLINS BUILDING & CONTRACTING

On August 31, 2023, the Company entered into a stock purchase agreement with the owner of Collins Building & Contracting, Inc. (“Collins Building”) pursuant to which the owner agreed to sell all of the outstanding common stock of Collins Building to the Company in exchange for (a) cash consideration of $1,000,000, (b) a five-year secured promissory note in the principal amount of $2,000,000, bearing interest at 7.0% per annum (the “First Promissory Note”), and (c) a two-year secured promissory note in the principal amount of $2,035,250, bearing interest at 8.25% per annum (the “Second Promissory Note”). The First Promissory Note is secured by the acquired real property and quarry infrastructure, and the Second Promissory Note is secured by the acquired equipment.

The Company accounted for the transaction as a business combination in accordance ASC 805 “Business Combinations”. The Company has performed an allocation of the purchase price paid for the assets acquired and the liabilities assumed. The fair values of the assets acquired are set forth below. Because the fair values exceeded the purchase price, a gain on the purchase of $1,875,150 was recognized. The allocation of the purchase price is based on management’s estimates and a third-party assessment of the fair value of the equipment purchased.

Fair value of assets acquired:
Equipment	$	6,156,000
Land		554,900
Buildings		199,500
Total assets acquired		6,910,400
Less: Gain on bargain purchase price		(1,875,150	)
Purchase price	$	5,035,250
Cash consideration		1,000,000
Long-term notes issued to the seller		4,035,250
Total purchase price	$	5,035,250
Acquisition transaction costs incurred	$	167,212

Collins Building’s operations contributed revenues of $0 and net loss of $274,081 to the Company’s consolidated revenues and net loss for the three months ended June 30, 2024. For the six months ended June 30, 2024, Collins Building’s operations contributed no revenue and a net loss of $544,836. The losses stem primarily from depreciation of equipment and buildings purchased as part of the Collins Building acquisition. Collins Building did not contribute any revenue or net income to the Company’s consolidated revenues and net income for the three months and six months ended June 30, 2023. All of the Company’s revenue generated by providing reclamation services on abandoned mine land, which was historically the core business of Collins Building, has been recorded in the books and records of Range Environmental.

3. GOODWILL

Goodwill is $751,421 at June 30, 2024 and at December 31, 2023. The goodwill as of both dates represents the value of the Range Reclamation Entities’ employee relations. Goodwill by reportable segment is as follows:

SCHEDULE OF GOODWILL

	June 30, 2024		December 31, 2023
Environmental Services:
Beginning Balance	$	751,421	$	751,421
Acquisitions		-		-
Adjustments		-		-
Ending Balance	$	751,421	$	751,421

4. STOCK OPTIONS

Stock options issued during the three months ended June 30, 2024 and the three months ended June 30, 2023

During the three months ended June 30, 2024, the Company granted options to an officer to purchase 250,000 shares of the Company’s common stock with an exercise price of $0.38 per share that expire ten years from the date of grant. Options to 125,000 shares vested upon grant and options to purchase 125,000 vest in one year. The fair value of the option award was estimated on the date of grant using the Black-Scholes-Merton Option Pricing model based on the following assumptions: (i) volatility rate of 267.24%, (ii) discount rate of 4.70%, (iii) zero expected dividend yield, and (iv) expected life of 10 years, which is the term of the options. The total fair value of the option grants at their grant dates was approximately $95,000, $47,500 of which was allocated to general and administrative expenses during the three months ended June 30, 2024.

During the three months ended June 30, 2023, the Company granted options to two outside advisors to purchase an aggregate of 400,000 shares of the Company’s common stock with exercise prices of $0.18 per share that expire five years from the date of grant. Options to purchase 200,000 shares vested upon grant and options to purchase 200,000 vest over two years. The fair value of each option award was estimated on the date of grant using the Black-Scholes-Merton Option Pricing model based on the following assumptions: (i) volatility rate between 273.24% and 273.87%, (ii) discount rate between 1.4% and 1.55%, (iii) zero expected dividend yield, and (iv) expected life of 5 years, which is the term of the options. The total fair value of the option grants at their grant dates was approximately $71,840, $35,920 of which was allocated to general and administrative expenses during the three months ended June 30, 2023.

During the three months ended June 30, 2024, the Company recorded $51,990 in stock-based compensation expense. For the three months ended June 30, 2023, the Company recorded $35,920 stock-based compensation expense related to vested stock options. At June 30, 2024, there was $60,970 of unamortized cost of the outstanding stock-based awards.

A summary of the Company’s stock option activity during the six months ended June 30, 2024 is as follows:

SUMMARY OF STOCK OPTION ACTIVITY

	Shares			Weighted Average Exercise Price
Balance outstanding at December 31, 2023		11,392,544		$	0.47
Granted		250,000			0.38
Exchanged		-			-
Exercised		-			-
Expired		(23,334	)		4.09
Forfeited		-			-
Balance outstanding at June 30, 2024		11,619,210		$	0.45
Balance exercisable at June 30, 2024		11,394,210		$	0.46

At June 30, 2024, the 11,619,210 outstanding stock options had $875,480 of intrinsic value.

A summary of the Company’s stock options outstanding as of June 30, 2024 is as follows:

SCHEDULE OF STOCK OPTION OUTSTANDING

	Number of Options		Weighted Average Exercise Price		Weighted Average Grant- Date Stock Price
Options Outstanding, June 30, 2024		100,000	$	0.1337	$	0.1337
		3,050,000	$	0.18	$	0.18
		1,550,000	$	0.212	$	0.212
		1,150,000	$	0.277	$	0.277
		750,000	$	0.30	$	0.30
		2,000,000	$	0.35	$	0.35
		250,000	$	0.38	$	0.38
		1,664,542	$	0.50	$	0.50
		128,000	$	0.96	$	0.96
		350,834	$	1.50 - 1.95	$	1.50 - 1.95
		597,500	$	2.00 - 2.79	$	2.00 - 2.79
		28,334	$	3.10 - 3.50	$	3.10 - 3.50
		11,619,210

A summary of the Company’s stock options outstanding and exercisable as of June 30, 2024 is as follows:

	Number of Options		Weighted Average Exercise Price		Weighted Average Grant- Date Stock Price
Options Outstanding and Exercisable, June 30, 2024		100,000	$	0.1337	$	0.1337
		2,950,000	$	0.18	$	0.18
		1,550,000	$	0.212	$	0.212
		1,150,000	$	0.277	$	0.277
		750,000	$	0.30	$	0.30
		2,000,000	$	0.35	$	0.35
		125,000	$	0.38	$	0.38
		1,664,542	$	0.50	$	0.50
		128,000	$	0.96	$	0.96
		350,834	$	1.50 - 1.95	$	1.50 - 1.95
		597,500	$	2.00 - 2.79	$	2.00 - 2.79
		28,334	$	3.10 - 3.50	$	3.10 - 3.50
		11,394,210

5. WARRANTS

A summary of warrants to purchase common stock issued during the six months ended June 30, 2024 is as follows:

SCHEDULE OF WARRANTS ACTIVITY

	Shares		Weighted Average Exercise Price
Balance outstanding and exercisable at December 31, 2023		3,313,335	$	0.66
Granted		-		-
Exercised		-		-
Expired		-		-
Balance outstanding and exercisable at June 30, 2024		3,313,335	$	0.66

At June 30, 2024, the 3,313,335 outstanding stock warrants had $15,000 of intrinsic value.

6. NOTES PAYABLE

The Company had no notes payable outstanding as of June 30, 2024, or December 31, 2023.

7. LINE OF CREDIT

In November 2022, the Company secured a bank line of credit with a limit of $1,000,000. In November 2023, the Company amended and restated this line of credit. The line of credit, as amended, has a maturity date of November 30, 2024, and bears interest at one percent (1%) above the bank’s prime rate (prime rate plus one percent margin equaled 9.50% at June 30, 2024). As of June 30, 2024, the balance due under the line of credit was $1,000,000. As of December 31, 2023, the balance due under the line of credit was $1,000,000.

In June 2023, Range Environmental secured a bank loan with a limit of $1,000,000. In November 2023, the loan amount was increased to $1,400,000 pursuant to which principal and accrued interest payments are required in March, June, September and December 2024. The loan has a maturity date of December 31, 2024, and bears interest at the bank’s prime rate (prime rate equaled 8.50% at June 30, 2024). As of June 30, 2024, the balance due under the loan was $1,200,000. As of December 31, 2023, the balance due under the loan was $1,400,000.

8. LONG-TERM DEBT OBLIGATIONS

Long-term debt consists of debt on vehicles and equipment, which serves as the collateral, and debt issued as part of the acquisition of Collins Building.

Interest rates on the equipment financings range from 3.69% to 9.95% for 2024 and mature between 2025 through 2029.

The Collins Building debt consists of a five-year secured promissory note with an original principal amount of $2,000,000, bearing interest at 7.0% per annum (the “First Promissory Note”), and a two-year secured promissory note with an original principal amount of $2,035,250, bearing interest at 8.25% per annum (the “Second Promissory Note”, and, together with the First Promissory Note, the “Collins Promissory Notes”). The First Promissory Note is secured by the acquired real property and quarry infrastructure and the Second Promissory Note is secured by the acquired equipment. At June 30, 2024, the First Promissory Note had an outstanding balance of $1,713,505 and the Second Promissory Note had an outstanding balance of $1,227,331.

A summary of payments due under the long-term debt by year is as follows:

	Equipment Financing		Collins Promissory Notes

2024 – due between July 1, 2024 and June 30, 2025	$	1,206,455	$	1,410,989
2025 – due between July 1, 2025 and June 30, 2026		869,454		576,105
2026 – due between July 1, 2026 and June 30, 2027		791,242		422,587
2027 – due between July 1, 2027 and June 30, 2028		644,147		452,644
2028 and later – due on July 1, 2028 and thereafter		364,129		78,511
Total long-term debt	$	3,875,427	$	2,940,836

9. MAJOR CUSTOMER AND CONCENTRATION OF CREDIT RISK

Sales to the Company’s two largest customers constituted 92% and 89% of total sales for the three months ended June 30, 2024 and the six months ended June 30, 2024, respectively. Sales to the Company’s largest customer were 94% and 92% of total sales for the three months ended June 30, 2023 and the six months ended June 30, 2023, respectively.

Accounts receivable from the same customers were 99% of total accounts receivable as of June 30, 2024 and 70% as of December 31, 2023.

10. EARNINGS PER COMMON SHARE

The following table sets forth the computation of basic and diluted earnings per share.


	Three Months Ended June 30,					Six Months Ended June 30,
	2024			2023		2024			2023
Earnings Per Share - Basic
Net (loss)/income	$	(1,225,681	)	$	36,762	$	(2,439,521	)	$	(190,098	)
Weighted average shares of common stock outstanding - Basic		101,552,586			80,519,745		101,288,035			79,324,917
Earnings Per Share - Basic	$	(0.01	)	$	0.00	$	(0.02	)	$	(0.00	)

Earnings Per Share - Diluted
Weighted average shares of common stock outstanding - Basic		101,552,586			80,519,745		101,288,035			79,324,917
Unvested Restricted Stock Awards		-			-		-			-
Weighted average shares of common stock - Diluted		101,552,586			80,519,745		101,288,035			79,324,917
Earnings Per Share - Diluted	$	(0.01	)	$	0.00	$	(0.02	)	$	(0.00	)

11. COMMITMENTS AND CONTINGENCIES

From time to time, the Company is involved in legal matters arising in the ordinary course of business. While the Company believes that such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have an adverse effect on its business, financial condition or results of operations.

12. SEGMENT INFORMATION

ASC 280, “Segment Reporting” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organizational structure as well as information about services, categories, business segments and major customers in financial statements. The Company has six reportable segments that are based on the following business units: (i) Range Reclaim; (ii) Range Minerals; (iii) Range Water; (iv) Range Security; (v) Range Land; and (vi) Graphium Biosciences. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision-maker has been identified as the Company’s Chief Executive Officer, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in (i) economic characteristics, (ii) nature of products and services, and (iii) procurement, manufacturing and distribution processes.

The six reportable segments that result from applying the aggregation criteria are as follows:

●	Range Reclaim – land reclamation, water restoration and land repurposing

●	Range Minerals – subcontracted mining and reclamation activities

●	Range Water – biochar product development and water solutions business

●	Range Security – security services on mine land being reclaimed and repurposed for non-fossil fuel uses

●	Range Land – mine land being acquired, reclaimed and repurposed for non-fossil fuel uses

●	Graphium Biosciences – glycosylated cannabinoid drug development program

The Company had no inter-segment sales for the periods presented.

Summarized financial information concerning the Company’s reportable segments is shown as below:

By Categories


	For the Three Months Ended June 30, 2024
	Range Reclaim			Range Minerals			Range Water			Range Security		Range Land		Graphium Biosciences			Corporate			Total

Sales	$	2,050,958		$	138,118		$	-			160,662	$	-	$	-		$	-		$	2,349,738
Gross profit		(252,848	)		20,842			-			83,077		-		-			-			(148,929	)
Net income (loss)		(579,928	)		(84,121	)		(5,154	)		57,302		-		(157,275	)		(456,505	)		(1,225,681	)

Total assets		12,966,495			4,453,028			12,579			226,846		1,008,940		9,147			764,485			19,441,520
Depreciation		634,906			-			639			2,892		-		-			-			638,437
Interest expense		61,195			-			-			-		-		-			104,465			165,660
Tax expense		-						-			-		-		-			56,600			56,600
Capital expenditures for long-lived assets	$	-		$	-		$	-			-	$	-	$	-		$	-		$	-


	For the Three Months Ended June 30, 2023
	Range Reclaim		Range Water			Range Security		Range Land		Graphium Biosciences			Corporate			Total

Sales	$	3,882,492	$	-		$	115,775	$	-	$	-		$	-		$	3,998,267
Gross profit		789,687		-			55,414		-		-			-			845,101
Net income (loss)		433,922		(19,116	)		37,550		-		(107,444	)		(308,150	)		36,762

Total assets		9,440,020		15,138			94,610		-		8,784			156,928			9,715,480
Depreciation		338,409		426			2,891		-		-			-			341,726
Interest expense		63,061		-			224		-		-			1,712			64,997
Tax expense		-		-			-		-		-			-			-
Capital expenditures for long-lived assets	$	38,289	$	-		$	-	$	-	$	-		$	-		$	38,289


	For the Six Months Ended June 30, 2024
	Range Reclaim			Range Minerals		Range Water			Range Security		Range Land		Graphium Biosciences			Corporate			Total

Sales	$	3,556,941		$	2,120,233	$	-		$	582,457	$	-	$	-		$	-		$	6,259,631
Gross profit		(832,531	)		357,654		-			344,802		-		-			-			(130,075	)
Net income (loss)		(1,626,300	)		152,455		(38,736	)		289,542		-		(288,915	)		(927,567	)		(2,439,521	)

Total assets		12,966,495			4,453,028		12,579			226,846		1,008,940		9,147			764,485			19,441,520
Depreciation		1,269,811			-		1,279			5,782		-		-			-			1,276,872
Interest expense		154,173			-		-			-		-		-			186,745			340,918
Tax expense		-					-			-		-		-			56,600			56,600
Capital expenditures for long-lived assets	$	-		$	-	$	-		$	-	$	-	$	-		$	-		$	-


	For the Six Months Ended June 30, 2023
	Range Reclaim		Range Water			Range Security		Range Land		Graphium Biosciences			Corporate			Total

Sales	$	6,870,979	$	-		$	142,175	$	-	$	-		$	-		$	7,013,154
Gross profit		1,428,266		-			65,837		-		-			-			1,494,103
Net income (loss)		620,565		(38,280	)		20,445		-		(213,621	)		(579,207	)		(190,098	)

Total assets		9,440,020		15,138			94,610		-		8,784			156,928			9,715,480
Depreciation		691,165		426			4,319		-		-			-			695,910
Interest expense		105,811		-			224		-		-			2,599			108,634
Tax expense		-		-			-		-		-			-			-
Capital expenditures for long-lived assets	$	716,491	$	15,350		$	52,674	$	-	$	-		$	-		$	784,515

13. SUBSEQUENT EVENTS

None.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Statement

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our Unaudited Consolidated Financial Statements and the related notes thereto contained in Part I, Item 1 of this Quarterly Report. The information contained in this Quarterly Report on Form 10-Q is not a complete description of our business or the risks associated with an investment in our common stock. We urge you to carefully review and consider the various disclosures made by us in this Quarterly Report and in our other reports filed with the Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K/A for the year ended December 31, 2023 filed on August 8, 2024, and the related audited financial statements and notes included therein.

Certain statements made in this Quarterly Report on Form 10-Q constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). Forward-looking statements are projections in respect of future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “intend,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause our or our industry’s actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. These risks and uncertainties include: general economic and financial market conditions; our ability to obtain additional financing as necessary; our ability to continue operating as a going concern; any adverse occurrence with respect to our business or; results of our research and development activities that are less positive than we expect; our ability to bring our intended products to market; market demand for our intended products; shifts in industry capacity; product development or other initiatives by our competitors; fluctuations in the availability and costs of raw materials required in our drug development process; other factors beyond our control; and the other risks described under the heading “Risk Factors” in our Annual Report on Form 10-K/A filed with the SEC on August 8, 2024.

Although we believe that the expectations and assumptions reflected in the forward-looking statements we make are reasonable, we cannot guarantee future results, levels of activity or performance. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those expressed by any forward-looking statements. As a result, readers should not place undue reliance on any of the forward-looking statements we make in this report. Forward-looking statements speak only as of the date on which they are made. Except as required by law, we undertake no obligation to revise or update publicly any forward-looking statements for any reason.

Company Overview

Range is a public company dedicated to improving the health and wellness of people and the planet through a novel and innovative approach to impact investing. We own and operate several complementary operating businesses focused on developing long-term solutions to environmental, social, and health challenges, with a particular focus on acquiring, reclaiming and repurposing mine sites and other undervalued land in economically disadvantaged communities throughout Appalachia. Range takes an opportunistic approach to impact investing by leveraging its competitive advantages and looking at solving old problems in new ways. Range seeks to thoughtfully allocate its capital into strategic opportunities that are expected to make a positive impact on the people-planet ecosystem and generate strong investment returns for its shareholders.

Our corporate headquarters is located in Cleveland, Ohio, with additional office locations in Flatwoods, West Virginia, Fola, West Virginia and Rocklin, California. As of August 13, 2024, we employed 44 full-time employees. In addition, we have, from time to time, engaged various consultants and professional service firms to provide us with flexible and experienced resources to advance our corporate objectives in order to maintain a cost-effective overhead structure. We strive to instill a corporate culture of honesty, integrity and respect while advancing our mission of doing well by doing good.

Impact Investing Strategy

Our impact investing strategy aims to improve the health and wellness of people and the planet, while also generating long-term sustainable financial returns for our shareholders. We believe that doing well and doing good are not mutually exclusive, and that an impact investing strategy can balance the environmental, social and economic needs of people and the planet while also generating attractive risk-adjusted financial returns for shareholders.

Our impact investing strategy provides an opportunity for our dedicated team to address pressing environmental, social and economic challenges, such as air and water pollution, educational inequality and economic disparity, and climate change, through the development of technology-based solutions. By actively directing investment capital towards businesses that are working to create positive environmental, social and economic outcomes, we believe that our impact investing strategy can contribute to an improved people-planet ecosystem and a healthier and happier way of life.

We have a particular interest in providing environmental and social solutions in economically-disadvantaged regions of the United States. Initially, the Company is targeting the Appalachian region, which is home to communities with some of the most disadvantaged income, education and employment demographics in the United States. Our ambitious strategy is to allocate investment capital and build operating businesses that provide positive environmental and social impact in the disadvantaged coal communities of Appalachia to maximize the good we can do for people and the planet.

Operating Business Segments

Our six operating business segments are: (i) Range Reclaim; (ii) Range Minerals; (iii) Range Water; (iv) Range Security; (v) Range Land; and (vi) Graphium Biosciences.

Range Reclaim

In May 2022, the Company acquired Range Environmental Resources, Inc., a West Virginia corporation (“Range Environmental”). Range Environmental provides land reclamation and water restoration services to customers throughout the Appalachian region with the goal of returning land to pre-mining conditions or repurposing the land for natural, commercial, agricultural or recreational use. Range Environmental’s water restoration services seek to improve the water quality of rivers, streams and discharges through novel and innovative treatment applications to help customers meet their various regulatory standards and requirements.

According to the U.S. Energy Information Administration (“EIA”), the United States had 551 coal mines in 2020, comprised of 370 active mines, 141 idled or closed mines, and 40 new or activated mines. Approximately 82% of those coal mines were located in Appalachia (which comprises the Appalachian Mountains and is commonly known as the cultural region in the Eastern United States stretching from the southern part of New York to the northern parts of Alabama and Georgia). According to the EIA, there were approximately three times as many coal mines in the United States in 2008 compared to 2020 with approximately 89% located in Appalachia. The precipitous decline in the number of operating coal mines since 2008 is due to various supply, demand and regulatory factors, including a reduction in demand for coal as a source of electricity due to the increased use of natural gas and renewable energy, an increase in coal production costs due to inflation, the dearth of cost-effective locations remaining for mining, and a more stringent and costly regulatory environment, all of which have resulted in an increasingly difficult market for coal producers.

In 2000, coal was responsible for 1,966 billion kWh of electricity generation, which represented 52% of the total electricity generation in the United States. By contrast, in 2022, coal was responsible for only 828 billion kWh of electricity generation, which represented 20% of the total electricity generation in the United States. According to the EIA, 23% of the 200,568 megawatts of coal-fired capacity currently operating in the United States is scheduled to be retired by the end of 2029 due to the high cost of operations, continued competition from natural gas and renewable energy resources, and sustainable initiatives of energy producers.

However, the reclamation of closed and inactive mine sites has not kept pace with the increase in closed and idled mine sites, thus creating a substantial backlog of reclamation work that needs to be completed on former mine sites. According to the U.S. Office of Surfacing Mining Reclamation and Enforcement (“OSMRE”), there are approximately 50,000 high-priority abandoned mine land locations in the United States resulting from legacy coal mining operations that failed to adequately reclaim the land and waterways back to their natural state. Additionally, there are tens of thousands of active mine sites in the United States that require contemporaneous reclamation of land and waterways during the active mining process, and an estimated equally large number of idled mine locations that also require significant land reclamation and water restoration services.

Under the Surface Mining Control and Reclamation Act of 1977 (“SMRCA”), OSMRE was established for two basic purposes: (i) to ensure coal mines in the United States operate in a manner that protects citizens and the environment during mining operations and to restore the land to beneficial use following mining; and (ii) to implement an Abandoned Mine Land (“AML”) reclamation program to address the hazards and environmental degradation resulting from two centuries of coal mining activities that occurred before SMRCA was passed in 1977. The AML reclamation program is funded through fees levied against coal producers based on tons of coal produced. As of September 2020, the AML reclamation fund had collected a total of $11.7 billion in coal mining fees over the life of the program, with $9.5 billion (81%) appropriated and distributed in accordance with SMCRA, and $2.2 billion (19%) unappropriated and available for future disbursement. In November 2021, the Infrastructure Investment and Jobs Act was enacted, which, among other things, authorized $11.3 billion in new funding to be appropriated for deposit into the AML reclamation fund. Importantly, the AML reclamation fund is only available to help fund the reclamation of mines abandoned before SMCRA was enacted in 1977; therefore, all mines abandoned after the year 1977 cannot access funding from the AML reclamation fund and must obtain funding from other sources.

While much of the funding for this reclamation work comes from the federal government, each state in Appalachia has a Department of Environmental Protection or an equivalent agency (“DEP”) that oversees coal mining permitting, operations, and reclamation. Under DEP rules and regulations, coal mining companies are required to develop a mining and reclamation plan that is approved by the applicable state agency, obtain a mining permit from the state, and secure a reclamation surety bond from a qualified third-party insurance company or provide a comparable financial guarantee. The reclamation surety bond provides the state with financial assurances that land reclamation and waterway restoration will be performed in accordance with the original reclamation plan once mining is complete if the coal mining company, as primary obligor, fails to perform. Therefore, there are at least three groups who may need land reclamation, water restoration and environmental auditing services: (i) mining companies when permits are active and reclamation bonds are not in default; (ii) surety bond insurers when reclamation bonds are in default; and (iii) states through their AML reclamation funds for mine lands abandoned before 1977 and for mine lands with defaulted coal mining companies and surety bond insurers after 1977.

Range Environmental is planning for continued growth in its land reclamation, water restoration and consulting businesses by expanding its market share with existing coal mining customers and reclamation bond insurers, adding new coal mining and non-coal mining customers, and collaborating with the Company’s other operating businesses to generate incremental sales opportunities. We will seek to add additional people, equipment and technologies to support our ambitious growth goals to ensure we successfully execute our value creation plans for the Company and our shareholders.

In August 2023, the Company acquired Collins Building & Contracting, Inc. (“Collins Building”), a West Virginia-based environmental services business focused on performing reclamation services on abandoned mine lands throughout West Virginia. Collins Building, along with Range Environmental, are classified within the Range Reclaim operating business segment.

Range Minerals

In May 2022, the Company acquired Range Natural Resources, Inc., a West Virginia corporation (“Range Natural”). During the six months ended June 30, 2024, Range Natural had no mining employees or equipment and engaged an independent, third-party contractor responsible for all aspects of providing coal mining and reclamation services on a surface coal mine at the Fola Mine Complex in Fola, West Virginia (“Fola Mine”). In January 2024, the Company separated Range Natural’s results from the “Range Reclaim” reporting segment and has included Range Natural’s results in a new “Range Minerals” reporting segment. The Company believes reporting the results of Range Minerals separately from Range Reclaim will provide better insight and transparency into the overall operational performance of both operating business segments. On June 30, 2024, Range Natural terminated its agreement with the independent, third-party contractor that performed coal mining and reclamation services at the Fola Mine due to a failure to perform.

Range Water

Terra Preta, LLC, an Ohio limited liability company (“Terra Preta”), is a biochar product development and environmental solutions business started by the Company in December 2022. Terra Preta is developing a novel and innovative combination of biochar, proprietary materials and structural designs intended to create several first-of-its-kind agricultural and water filtration products and solutions.

Biochar is a solid, lightweight carbon-rich material produced by the thermal decomposition of organic material (such as cellulosic feedstock, including wood and plants) using a chemical-conversion process known as pyrolysis. Carbonization pyrolysis is a chemical degradation process that heats organic materials to produce carbon-rich biochar, liquid bio-oils, and syngas products. Since organic material is thermally decomposed without oxygen during the pyrolysis process, combustion does not occur, so the process allows for the permanent capture of carbon in the biochar end-product and eliminates the release of climate-damaging carbon dioxide into the atmosphere. The specific yield of biochar during the carbonization pyrolysis process depends on several variables such as temperature, heating time and heating rate. Lower temperatures, longer heating times and lower heating rates typically yield more biochar and less bio-oil and syngas.

Terra Preta has been launched to build a full-cycle, carbon-negative business that reduces greenhouse gases from the atmosphere, passively filters contaminated water without the use of harsh chemicals, and provides a fortified, nutrient-rich soil amendment to improve the growth of agricultural products.

Greenhouse gases, comprised of carbon dioxide, methane, nitrous oxide and fluorinated gases, are gases that trap heat in the atmosphere, and are generally believed to result in warmer temperatures and climate change, including changing weather patterns, rising sea levels, and more extreme weather events. Carbon dioxide enters the atmosphere through, among other things, the burning of fossil fuels, solid waste and other biomass materials, and is removed from the atmosphere when absorbed by plants during the photosynthesis process. Terra Preta is in discussions with a large affiliated landowner to enter into a long-term lease or purchase of at least 100 acres of former mine land in West Virginia for the planting, growth and harvesting of crops to serve as the primary feedstock for our biochar production operations. The newly planted crops would then act as a “carbon sink”, drawing substantial amounts of carbon dioxide from the atmosphere into the plants through the photosynthesis process. When the plants are harvested, biochar is produced through the carbonization pyrolysis process and the captured carbon dioxide is permanently preserved as carbon in the biochar product for use in water treatment and agricultural end uses.

Pursuant to rules adopted under the Clean Water Act of 1972 (“Clean Water Act”), the U.S. Environmental Protection Agency (“EPA”) has implemented various pollution control programs such as wastewater standards for industry and recommendations for pollutants in surface waters. The Clean Water Act prohibits any party from discharging pollutants into a water of the United States unless they have a permit issued under the National Pollutant Discharge Elimination System (“NPDES”), which contains limits on what a party can discharge and establishes monitoring and reporting requirements. On mining sites, coal operators are required to sample and test their water discharges on a regular basis to ensure compliance with the Clean Water Act and applicable NPDES permits. Currently, most mining operators treat non-compliant water with temporary holding ponds and expensive chemicals such as pH adjusters, coagulants and flocculants that require constant reapplication to ensure compliance. Terra Preta will focus on developing a proprietary, biochar-based passive treatment system that treats non-compliant mine site discharges to ensure compliance with the Clean Water Act and NPDES permits without the need for holding ponds or expensive chemicals.

Sustainable agriculture plays a critical role in the stability, growth, and diversification of our future food supply chain and the growth of plants intended to serve as a carbon sink to reduce greenhouse gases. High-quality soil, a key condition for sustainable agriculture, requires organic matter, microorganisms, nutrients, and optimal compaction. Subsoils with a sufficient number of air-filled pores have little restriction to drainage and aeration, and typically are able to decompose and cycle organic matter and nutrients more efficiently. Alternatively, soil with poor aeration leads to the build-up of carbon dioxide, reduces the ability of plants to absorb water and nutrients, and leads to increased plant stress and root disease. To help address the ill effects of soil compaction, Terra Preta is developing a proprietary, fortified biochar soil amendment that provides unique soil structuring characteristics that will allow plants to grow strong roots that optimize the absorption of water and nutrients, thereby reducing root stress and disease.

In December 2022, Terra Preta filed trademarks for biochar goods and services related to agricultural and water treatment applications. In March 2023, Terra Preta filed provisional patents related to novel and innovative agricultural and water treatment solutions and designs. Additionally, in March 2023, Terra Preta purchased two pyrolysis ovens with the capacity to produce one ton of biochar per day to advance our research and development activities. We are currently evaluating the purchase of a large continuous-process pyrolysis oven to increase the scale of our biochar production to commercial levels.

Range Security

Range Security Resources, LLC, an Ohio limited liability company (“Range Security”), is an environmental security services business started by the Company in November 2022. Range Security is focused on providing eco-friendly, technology-driven security services to active and former mine sites, with a particular focus on locations transitioning from coal mining to next generation industries and uses. Range Security is intended to serve as a complementary business to the Range Reclaim and Range Minerals entities.

Mine sites in the Appalachian region frequently comprise thousands of acres of natural habitat with valuable infrastructure and operating assets disbursed across large tracts of land. However, many of these mine sites lack adequate broadband access or cellular service, and therefore traditional technology-based security solutions are not available. Also, due to the large land areas and often challenging access roads and mountainous terrain, consistent visual confirmation of the safety and security of high value assets is problematic, and unnecessary amounts of carbon dioxide are emitted from heavy-duty trucks used to perform frequent visual security checks. Furthermore, due to the remoteness and lack of technological options, most security services in the market fail to provide an independent verification of the security status of a mine site and confirmation of visual security checks, resulting in a customer’s uncertainty regarding the actual security services being provided.

Valuable assets commonly found on mine sites requiring high-levels of security services include office buildings, coal operation facilities such as preparation plants and loadout facilities, power stations and electrical lines, vehicles and heavy equipment, supplies and chemicals, and spare parts and components. These high-value assets are frequently the target of theft since all or parts of these assets can be easily removed from the mine site and sold for cash. Unfortunately, the actual damage to the operation resulting from this type of destructive theft is frequently many times the market value of the stolen item, primarily due to the losses resulting from the down-time of operations, the cost of repairs and replacement components, and the long-term damage to critical infrastructure that can be repurposed and used to attract next generation industries once the mining is complete.

In March 2023, Range Security was engaged by its first customer for environmental security services covering a 13,000-acre coal mine site in West Virginia. As of August 13, 2024, Range Security employed 7 security professionals, and is focusing its recruitment efforts on military veterans, police officers, and other professionals with security experience. Range Security has purchased two fuel-efficient utility task vehicles for ground surveillance and a thermal-imaging drone for aerial surveillance, all of which use significantly less fuel and electricity to operate than traditional security vehicles and provide a much broader coverage range with a substantially lower carbon footprint. Range Security is also in the process of establishing satellite-based wireless service to support video surveillance and enable a mobile technology solution used by our security professionals to provide real-time evidence of visual security checks. Range Security plans to expand its security service business to additional mine sites, with a particular focus on locations with valuable infrastructure being repurposed into non-coal multi-use complexes with attractive job growth prospects and next generation industry opportunities.

Range Land

Range Land, LLC, an Ohio limited liability company (“Range Land”), is a land acquisition company started by the Company in August 2023. Range Land is focused on acquiring former mine lands with the goal of reclaiming and repurposing the sites for non-fossil fuel uses, including commercial, industrial, residential and recreational developments. Range Land is specifically focused on acquiring land to be used for renewable energy facilities, innovative agricultural installations, and projects focused on improving the quality and condition of our air, land and waterways.

According to industry estimates, Appalachia contains nearly one million acres of abandoned, idled and non-performing mine sites that are burdened with significant land reclamation and water restoration obligations. Many of these troubled mine sites are subject to mining permits and associated reclamation bonds, which as a result, prevents the land from being repurposed for non-mining uses until the land has been reclaimed and the permits and bonds have been released by the applicable state’s environmental protection department. Water quality is a particularly challenging issue since a permit can only be released if the site has at least 12-months of compliant water samples without active chemical treatment, which heightens the need for water restoration solutions to help transition former mine land to economically viable non-mining uses.

The Company has assembled the internal resources and capabilities to reclaim land, restore waterways, install innovative water treatment solutions, and secure the mine site to protect the significant historical investment in infrastructure. In addition, the Company has extensive knowledge and expertise regarding the permit and bond release process, which is a critical step necessary to unlock the underlying value of the former mine land for non-fossil fuel uses. Range Land is actively reviewing several mine sites throughout Appalachia to acquire, reclaim and repurpose in order to improve the land and create non-fossil fuel economic development opportunities for disadvantaged local coal communities.

In September 2023, Range Land, through its wholly-owned subsidiary CLV Azurite Land, LLC, an Ohio limited liability company (“CLV Azurite”), acquired over 1,900 acres of surface interest at an idled mine complex in West Virginia. CLV Azurite is in active discussions with the holder of the permits and bonds associated with the acquired land to ensure that the acquired surface acreage can be repurposed for alternative non-fossil fuel uses. Concurrently, CLV Azurite is in active discussions with two experienced and well-capitalized solar developers to convert the former mine land into a large solar energy facility on a majority of the acquired surface acreage, as well as additional acreage for commercial, industrial, recreational and residential development. Under the solar arrangements, CLV Azurite would be the landlord and the solar developer-operator would be the tenant required to pay CLV Azurite a negotiated lease payment on a per acre basis.

Graphium Biosciences

Graphium Biosciences, Inc., a Nevada corporation (“Graphium”), is a cannabinoid-based drug development company tracing its history of technological innovation and drug advancement back to October 2011 through two predecessor entities, Stevia First Corp. and Vitality Biopharma, Inc. In October 2021, the Company formed Graphium as a wholly-owned subsidiary and transferred all of its drug development assets to this newly-formed entity.

Graphium is advancing a broad portfolio of glycosylated cannabinoid prodrugs that have been developed to unlock the rebalancing effects of the endocannabinoid system to address numerous chronic conditions with inadequate pharmaceutical options. Graphium’s leading drug candidate, VBX-100, is a glycosylated tetrahydrocannabinol (“THC”) cannabinoid that targets inflammatory conditions of the gastrointestinal tract but without unwanted psychoactive or intoxicating side effects.

Cannabinoids, including THC and cannabidiol (“CBD”), have well-known therapeutic benefits through their interaction with the human endocannabinoid system, which serves a regulating and rebalancing function in the body. For decades, patients have used cannabinoids to activate the endocannabinoid system to provide relief for numerous chronic and debilitating ailments, including inflammation, pain, anxiety, depression, and cancer. However, THC, a commonly-used cannabinoid with significant therapeutic benefit, is psychoactive and intoxicating, and therefore its use has many practical, and in some cases legal, limitations. Nevertheless, many patients with chronic health conditions, including gastrointestinal inflammation, continue to use cannabinoids because current pharmaceutical offerings do not provide adequate therapeutic relief or result in unwanted side effects.

Our novel scientific discovery was the development of a proprietary enzymatic bioprocessing technology that adds one or more glucose molecules to a cannabinoid, resulting in our proprietary glycosylated cannabinoid compounds. Our glycosylated cannabinoids act as prodrugs that achieve targeted delivery of the bioactive cannabinoids within the body once they are activated. Prodrugs are compounds that, after administration, are metabolized into a pharmacologically active drug and are often designed to improve drug properties and reduce known or expected toxicities and adverse side effects. The advantages of our glycosylated cannabinoid prodrugs may include: (i) administration in a convenient oral formulation; (ii) targeted delivery with release in the colon or large intestine; (iii) improved stability with limited degradation or drug metabolism; and (iv) delayed release enabling longer-lasting effects and fewer administrations by patients.

We have learned through our animal studies that glucose bound to cannabinoid molecules are inactive and poorly absorbed from the intestines, allowing the combined molecule to reach the large intestine where glycoside hydrolase enzymes cleave the glucose and the cannabinoid is released in a targeted and restricted manner. Further, we have learned through our animal studies that a targeted release of THC, which could be provided in very low doses to achieve physiologically beneficial results, serves as an anti-inflammatory agent in the lower gastrointestinal tract and minimizes the amount of THC absorbed into the blood stream. Therefore, we anticipate our glycosylated cannabinoid prodrug will provide the anti-inflammatory benefits of low-dose THC while avoiding the psychoactive and intoxicating properties that hinder the broader pharmaceutical use of THC. Initially, we are targeting the $20 billion inflammatory bowel disease (“IBD”) market in the United States, which is composed of patients suffering from ulcerative colitis and Crohn’s disease, both chronic and debilitating conditions with no cure. We also believe our glycosylated cannabinoids could also be used to treat other indications, including, among others, irritable bowel syndrome (“IBS”), anxiety, depression, autism and cancer.

By using our proprietary enzymatic bioprocessing technologies, our research team has developed a novel family of over 100 glycosylated cannabinoid prodrugs. These glycosylated cannabinoids have unique commercial applications and patentable compositions of matter, which are separate and distinct from ordinary cannabinoids. Currently, our intellectual property is comprised of the following patents: (i) the Cannabinoid Glycoside Prodrugs and Methods of Synthesis patent filed in 2016 and granted in 2021 for the invention of novel glycosylated cannabinoids and methods of targeted delivery for the treatment of gastrointestinal disorders, including IBD and IBS; (ii) the Antimicrobial Compositions Comprising Cannabinoids and Methods of Using the Same patent filed in 2018 and granted in 2021 for the use of cannabinoids as antibiotics for the treatment of Clostridioides difficile; (iii) the Novel Cannabinoid Glycosides and Uses Thereof patent filed in 2020 and in prosecution for additional novel cannabinoid glycosides and includes research data supporting the improved characteristics and commercial production strategies for these new molecules; and (iv) the Continuous Enzymatic Perfusion Reactor System patent filed in 2021 and in prosecution for our improved reactor system for the efficient enzymatic glycosylation of hydrophobic small molecules, including cannabinoids. We believe our intellectual property portfolio of glycosylated cannabinoids possess significant value and, as a result, we have allocated substantial resources to ensure that our U.S. and international patents are properly filed and successfully prosecuted. As our research efforts involving glycosylated cannabinoids continue to progress, we plan to file additional patents to further expand our growing family of intellectual property assets and create long-term value for our shareholders.

Our research team has performed 23 animal studies to test the safety, efficacy and dosing levels of our glycosylated cannabinoids, which have provided us with favorable scientific data and the opportunity to further refine our drug development plan. We have performed two industry standard colitis disease mouse models: (i) TNBS model in 2017 and 2018 that generated favorable colitis prevention data; and (ii) DSS model in 2021 that generated favorable colitis treatment data. In 2021, we received a letter from the Food and Drug Administration’s (“FDA”) Office of Orphan Products Development stating that we have been granted Orphan Drug Designation for our glycosylated cannabinoid VBX-100 for the treatment of pediatric ulcerative colitis. An Orphan Drug Designation provides several benefits, including fee waivers, tax credits, fast tracking of regulatory processes, and seven years of market exclusivity.

Due to our development of pharmaceutical products, we are subject to extensive regulation by the FDA and other federal, state, and local agencies. Also, since we are researching and developing cannabinoid-based products, we are subject to regulation by the U.S. Drug Enforcement Administration (“DEA”). Our research and development activities focus on cannabinoids, particularly THC and CBD derived from the cannabis plant, which the DEA has classified as Schedule I substances. Schedule I substances are defined as drugs with no currently accepted medical use and a high potential for abuse. In May 2019, the DEA informed us that it had determined that they consider our VBX-100 prodrug a Schedule I substance. As a result, any developing, testing, manufacturing, or clinical studies involving our VBX-100 prodrug, and by inference potentially all of our THC-glycoside molecules, are required to be properly licensed by the DEA and adhere to strict diversion control standards.

We are working closely with a third-party contract research organization to develop a detailed drug development plan to advance our leading drug candidate, VBX-100, through Phase II clinical trials by the end of 2027, subject to receipt of sufficient funding, which is currently estimated to be approximately $20 million. Graphium has engaged a registered broker-dealer to assist with the capital raise, which remains in process.

Competition

Our Company is focused on a large and growing marketplace for impact investing initiatives, and therefore, is anticipated to face competition from a variety of operating businesses and investment funds who are developing similar business plans and operating strategies to satisfy the increasing demands of these types of investments in the marketplace. In many cases, these competitors are larger and better capitalized operating businesses and investment funds.

Our Company competes on the basis of a number of factors, including our geographic focus on Appalachia, access to mission-driven energy-transition capital, access to impact investing opportunities, strategic relationships with reclamation bond insurance companies, recruitment and retention of key personnel, market share with key customers, and supply relationships with critical vendors. Our ability to continue to compete effectively in our businesses will depend upon our ability to attract new employees and retain and motivate our existing employees.

Information Systems

In 2023, the Company engaged Foundation Software, LLC (“Foundation Software”) as its new accounting software provider and converted all of the Company’s accounting system operations from QuickBooks to Foundation Software during the second quarter of 2023.

Founded in Cleveland, Ohio in 1985, Foundation Software is specifically designed for service companies, particularly those in the construction, contracting and reclamation industries. Foundation Software offers the Company several enhanced features critical to the successful execution of its shareholder value creation plan, including: (i) general ledger accounting, including accounts payable, accounts receivable, inventory and customer billing; (ii) equipment tracking on job sites, maintenance, utilization and depreciation; (iii) employee tracking on job sites, time and materials, utilization, and billing; (iv) job costing and profitability reporting segmented by customers, job types and location’ and (v) numerous real-time management dashboard and key performance indicator reports that will allow management to closely monitor financial and operational performance and quickly react to business opportunities and issues. Furthermore, Foundation Software will allow the Company to quickly scale operations and efficiently and cost-effectively support the anticipated growth of each business, thereby preventing our accounting and management systems from becoming a limiting factor to our growth initiatives.

Results of Operations

Three Months Ended June 30, 2024 and June 30, 2023

The Company’s revenue for the three months ended June 30, 2024 was $2,349,738, its gross loss was $148,929 and net loss was $1,225,681. The Company’s revenue for the three months ended June 30, 2023 was $3,998,267, its gross profit was $845,101 and net income was $36,762. The $1,648,529 reduction in quarterly revenue was due to a $1,693,416 reduction in revenue from the Range Reclaim and Range Minerals business segments primarily due to a failure of performance by a mining subcontractor, which was partially offset by a $44,887 increase in revenue from the Range Security business segment primarily due to the performance of a new security services contract at a second mine site.

For the three months ended June 30, 2024, general and administrative expenses were $697,699 compared to $583,964 incurred for the three months ended June 30, 2023. This $113,735 increase in general and administrative expenses are primarily due to the costs of additional employees and consultants hired in anticipation of the projected long-term growth of the Range Reclaim and Range Minerals business segments, offset by the partial re-allocation to the Graphium Biosciences business segment of the salaries and benefits of a corporate executive.

For the three months ended June 30, 2024, the Company incurred research and development costs of $157,278 compared to $107,444 for the three months ended June 30, 2023. This $49,834 increase in research and development costs was due to the full allocation of employment costs of a corporate executive who was transitioned from the Company to the Graphium Biosciences business segment effective March 31, 2024.

For the three months ended June 30, 2024, the Company incurred net other expenses in the amount of $221,775 compared to net other expenses of $116,931 for the three months ended June 30, 2023. This $104,844 increase was primarily attributable to increased interest expense of $48,729 and state income taxes of $56,600 for the three months ended June 30, 2024. There was no state tax expense incurred during the three months ended June 30, 2023.

The net loss during the three months ended June 30, 2024 was $1,225,681 compared to net income of $36,762 for the three months ended June 30, 2023. This $1,262,443 decrease in net income was due to lower revenue of $1,648,529, lower gross profit of $994,030, higher operating expenses of $163,569 and higher other expense of $104,844.

Six Months Ended June 30, 2024 and June 30, 2023

The Company’s revenue for the six months ended June 30, 2024 was $6,259,631, its gross loss was $130,075 and net loss was $2,439,521. The Company’s revenue for the three months ended June 30, 2023 was $7,013,154, its gross profit was $1,494,103 and net loss was $190,098. The $753,523 reduction in revenue for the six months ended June 30, 2024 was related to a $1,193,805 reduction in revenue from the Range Reclaim and Range Minerals business segments primarily due to a failure of performance by a mining subcontractor, which decline was partially offset by a $440,282 increase in revenue from the Range Security business segment primarily due to its growth with its first customer and the performance of a new security services contract at a second mine site for the six months ended June 30, 2024.

For the six months ended June 30, 2024, general and administrative expenses were $1,641,600 compared to $1,310,012 incurred for the six months ended June 30, 2023. This $331,588 increase in general and administrative expenses are primarily due to the costs of additional employees and consultants hired in anticipation of the projected long-term growth of the Range Reclaim and Range Minerals business segments, offset by the partial re-allocation to the Graphium Biosciences business segment of the salaries and benefit of a corporate executive during the second quarter of 2024.

For the six months ended June 30, 2024, the Company incurred research and development costs of $288,918 compared to $213,621 for the six months ended June 30, 2023. This $75,297 increase in research and development costs was due to the full allocation of employment costs of a corporate executive who was transitioned from the Corporate business segment to the Graphium Biosciences business segment effective March 31, 2024, and costs associated with the capital raise process to advance its drug development program.

For the six months ended June 30, 2024, the Company incurred net other expenses in the amount of $378,928 compared to net other expenses of $160,568 for the six months ended June 30, 2023. This $218,360 increase was primarily attributable to increased interest expense of $180,350 and state income taxes of $56,600 for the six months ended June 30, 2024. There was no state tax expense incurred during the six months ended June 30, 2023.

The net loss during the six months ended June 30, 2024 was $2,439,521 compared to a net loss of $190,098 for the six months ended June 30, 2023. This $2,249,423 decrease in net income was due to lower revenue of $753,523, lower gross profit of $1,624,178, higher operating expenses of $406,885 and higher other expense of $218,360.

Liquidity and Capital Resources

As of June 30, 2024, the Company had total current assets of $6,655,093, comprised of: (i) cash of $123,713; (ii) accounts receivable of $4,388,785; (iii) contract assets of $1,374,962; (iv) inventory of $725,429 and (v) prepaid expenses of $42,204. As of June 30, 2024, the Company had total current liabilities of $7,058,714, comprised of: (v) outstanding amounts on the lines of credit of $2,200,000; (w) accounts payable of $2,036,868; (x) accrued expenses of $54,402, (y) deposit of $150,000 and (z) the current portion of long-term debt of $2,617,444. As a result, as of June 30, 2024, the Company had negative working capital of $403,621. As of December 31, 2023, the Company had positive working capital of $753,756. This $1,157, 377 decrease in working capital is the result of lower sales in the amount of $1,648,529 during the six months ended June 30, 2024, which has translated into lower non-cash current assets of $1,016,655 and lower non-debt current liabilities of $1,574,027, for a net decrease of non-cash and non-debt working capital of $557,362 during the six months ended June 30, 2024. Also, during the six months ended June 30, 2024, $2,053,087 of cash was used to fund the aforementioned $557,362 decrease of non-cash and non-debt working capital, repayment of $338,348 of the current portion of long-term debt, and the repayment of $1,051,208 of long-term debt.

As of June 30, 2024, the Company had long-term assets of $12,786,427, comprised of: (i) net equipment assets of $10,289,443; (ii) land of $1,563,797; (iii) buildings of $171,790; (iv) goodwill of $751,421; and (v) deposits of $9,976. As of June 30, 2024, the Company had long-term liabilities of $4,198,819, entirely comprised of long-term debt, net of current portion. As of December 31, 2023, the Company had long-term assets of $14,063,299, comprised of: (v) net equipment assets of $11,549,689; (w) land of $1,563,797; (x) building of $188,416; (y) goodwill of $751,421; and (z) deposits of $9,976. As of December 31, 2023, the Company had long-term liabilities of $5,250,027, entirely comprised of long-term debt, net of current portion.

Based on the Company’s current corporate strategy, we expect our general operating expenses to be substantially offset by revenue generated by the Range Reclaim and Range Security business segments, and the collection of significant outstanding accounts receivables from the Company’s largest customer. While we expect the Company’s operating businesses to generate operating losses over the 12 months following June 30, 2024, based on the Company’s current cash balance and the anticipated collection of significant outstanding accounts receivable, the Company expects to have sufficient funds to operate its business over the next 12 months. If additional capital is needed in excess of our current capital resources, we will explore financing options to accelerate the funding and execution of our growth strategy and shareholder value creation plan.

Our estimated total expenditures for the 12-month period ending June 30, 2025 could increase if we encounter unanticipated lower revenues and higher expenses in connection with operating our business as presently planned. In addition, our estimates of the amount of cash necessary to fund our business may prove to be too low, and we could spend our available financial resources much faster than we currently expect. If we cannot raise the capital necessary to continue to develop our business, we will be forced to delay, scale back or eliminate some or all of our proposed operations. If any of these were to occur, there is a substantial risk that our business would fail.

Until such time as the Company and its operating businesses are cash flow positive, we expect to continue funding our operations, at least in part, through equity and debt financings. However, sources of additional funds may not be available when needed, on acceptable terms, or at all. If we issue equity or convertible debt securities to raise additional funds or to fund, in whole or in part, acquisitions in furtherance of our business strategy, our existing stockholders may experience substantial dilution, and the new equity or debt securities may have rights, preferences and privileges senior to those of our existing stockholders. If we incur additional debt, we would incur additional interest expenses, and assuming those loans would be available, it would increase our liabilities and future cash commitments. Moreover, regardless of the manner in which we seek to raise capital, we may incur substantial costs in those pursuits, including investment banking fees, legal fees and other related costs.

Net Cash Used in Operating Activities

For the six months ended June 30, 2024, net cash used in operating activities was $1,663,531, compared to net cash used in operating activities of $398,399 for the six months ended June 30, 2023. This $1,265,132 increase was primarily due to a $2,249,423 increase in loss from continued operations that was primarily driven by reduced sales and profitability in our Range Reclaim and Range Minerals business segments, and higher costs of additional employees and consultants hired in anticipation of the projected long-term growth of those business segments, offset by higher non-cash depreciation expense of $580,962 due to the Company’s larger investment in equipment and a $382,769 reduction in cash used to fund the Company’s working capital.

Net Cash Used in Investing Activities

For the six months ended June 30, 2024, net cash used in investing activities was $0, compared to net cash provided by investing activities of $784,515 for the six months ended June 30, 2023. Net cash used in investing activities for the six months ended June 30, 2023 consisted of equipment purchases and capital expenditures. Based on the Company’s current corporate strategy, no additional equipment purchases are required to execute its near-term strategic plan; however, if additional equipment is required in the future, the Company anticipates securing such equipment through third-party equipment leases or equipment financings. Future capital expenditures required to maintain the Company’s existing equipment are anticipated to be funded with cash on hand.

Net Cash Provided By Financing Activities

For the six months ended June 30, 2024, the most significant items affecting the comparison of our cash flows (used in) provided by financing activities for the six months ended June 30, 2024 and 2023 are summarized below:

	●	During the six months ended June 30, 2024, we received aggregate proceeds of $1,410,000 from the sale of our common stock in privately-negotiated transactions.
	●	During the six months ended June 30, 2024, we repaid $1,389,556 of our indebtedness.
	●	During the six months ended June 30, 2023, we received proceeds of $383,202 from the issuance of long-term debt and $1,200,000 from a line of credit, offset by the repayment of long-term debt of $893,093.

Off-Balance Sheet Arrangements

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that would be material to stockholders.

Critical Accounting Policies

Our financial statements and accompanying notes included in this report have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) applied on a consistent basis. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.

We regularly evaluate the accounting policies and estimates that we use to prepare our financial statements. In general, management’s estimates are based on historical experience, on information from third party professionals, and on various other assumptions that are believed to be reasonable under the facts and circumstances. Actual results could differ from the estimates made by management.

We believe the following critical accounting policies require us to make significant judgments and estimates in the preparation of our consolidated financial statements included in this report:

Use of Estimates and Assumptions

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. The more significant estimates and assumption by management include, among others, assumptions used in valuing assets acquired in business acquisitions, reserves for accounts receivable, assumptions used in valuing equity instruments issued for services, the valuation allowance for deferred tax assets, accruals for potential liabilities, and assumptions used in the determination of the Company’s liquidity. Actual results could differ from those estimates.

Business Combinations

Business combinations are accounted for using the purchase method of accounting under ASC 805, “Business Combinations.” This method requires the Company to record assets and liabilities of the businesses acquired at their estimated fair values as of the acquisition date. Any excess of the cost of the acquisition over the fair value of the net assets acquired is recorded as goodwill. Determining the fair value requires management to make estimates and assumptions including discount rates, rates of return on assets, and long-term sales growth rates.

Goodwill

As referenced by ASC 350 “Intangibles- Goodwill and other” (“ASC 350”), management performs its annual test for goodwill at least annually or more frequently, if impairment indicators arise.

Revenue Recognition

The Company recognizes revenue under ASC 606, “Revenue from Contracts with Customers”. The core principle of the revenue standard is that a company should recognize revenue by analyzing the following five steps: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations; and (5) recognize revenue when (or as) each performance obligation is satisfied. The Company primarily invoices customers and recognizes revenue on a periodic basis for equipment and labor hours provided to a customer on a particular job based on an agreed-upon hourly rate sheet or a fixed amount for a project. The Company also invoices customers and recognizes revenue for equipment mobilization fees and materials and supplies required to complete a project. The Company invoices for the sales of chemicals and recognizes revenue when the products are delivered to the customer’s designated site. Costs for equipment, labor and chemicals are generally expensed as incurred since the projects are generally short-term and not subject to a contract. The Company also invoices customers for the provision of environmental security services on an agreed-upon hourly rate for each project. All revenue is recognized at a point in time.

Stock-Based Compensation

The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services.

Recent Accounting Pronouncements

Please refer to Footnote 1 of the accompanying financial statements for management’s discussion of recent accounting pronouncements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not Applicable.

Item 4. Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our Disclosure Controls and Procedures (“DCPs”) as of the end of the fiscal quarter ended March 31, 2024, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act.

Based on such evaluation at the time our Form 10-Q for the three months ended March 31, 2024 was filed, our Chief Executive Officer and Chief Financial Officer concluded that as of March 31, 2024, our DCPs were effective at a reasonable assurance level. Subsequent to that evaluation and as a result of the material weakness in our ICFR discussed below, our Chief Executive Officer and Chief Financial Officer have concluded that during the three-month period ended March 31, 2024, our disclosure controls and procedures were not effective. Our internal control over financial reporting did not result in the proper accounting classification of financial information and presentation which, due to its material impact on our financial statements, we determined to be a material weakness. Therefore, on August 8, 2024, the Company filed a Form 10-Q/A for the three months ended March 31, 2024, which corrected the accounting error of a vendor invoice that was inadvertently recorded in April 2024 rather than the proper period of March 2024.

Material Weaknesses in Internal Control over Financial Reporting

A material weakness is a deficiency, or a combination of deficiencies, in Internal Control over Financial Reporting (“ICFR”), such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected in a timely manner.

We did not maintain effective controls over expense recording and accruals. Specifically, we did not maintain effective controls to timely identify and account for period cutoff and accruals to the proper period. This material weakness resulted in the restatement of our financial statements for the three months ended March 31, 2024.

Remediation Plan

Upon identification of the material weakness, our management developed a remediation plan to address the material weakness, which includes updating our procedures regarding the review of expenses and accruals of expenses to the proper period.

Our management believes the measures described above and others that may be implemented will remediate the material weakness that we have identified. However, the material weakness will not be considered remediated until there has been appropriate time for us to conclude through testing that the controls are operating effectively.

As our management continues to evaluate and improve our ICFR, we may decide to take additional measures to address control deficiencies or determine to modify certain remediation measures identified.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the six months ended June 30, 2024, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. The impact and outcome of litigation, if any, is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are not currently a party to and our properties are not currently the subject of any material pending legal proceedings the adverse outcome of which, individually or in the aggregate, would be expected to have a material adverse effect on our financial position or results of operations.

Item 1A. Risk Factors

Please refer to the risks described under the heading “Risk Factors” in our Annual Report on Form 10-K/A filed with the SEC on August 8, 2024.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On June 17, 2024, the Company entered into a securities purchase agreement with Continental Heritage Holding Company LLC, a Florida limited liability company, providing for the issuance and sale of 3,703,704 shares of the Company’s common stock. The aggregate gross proceeds from the sale of these shares was approximately $1,000,000. The sale proceeds were used for general operating purposes.

Item 3. Defaults Upon Senior Securities: None

Item 4. Mine Safety Disclosures: None

Item 5. Other Information: None

Item 6. Exhibits

Exhibit Number		Description of Exhibit

2.1		Agreement and Plan of Merger, dated September 14, 2011, by and between Stevia First Corp. and Legend Mining Inc. (Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the SEC on October 14, 2011.)

3.1.1		Articles of Incorporation of Stevia First Corp. (Incorporated by reference to Exhibit 3.1 to the registrant’s Registration Statement on Form S-1 filed with the SEC on August 6, 2008 (File No. 333-152830).)

3.1.2		Certificate of Amendment of Articles of Incorporation of Vitality Biopharma, Inc. (Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the SEC on July 19, 2016.)

3.1.3		Articles of Merger, effective October 10, 2011 (Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the SEC on October 14, 2011.)

3.1.4		Certificate of Change, effective October 10, 2011 (Incorporated by reference to Exhibit 3.2 to the registrant’s Current Report on Form 8-K filed with the SEC on October 14, 2011.)

3.2.1		Bylaws of Stevia First Corp. (Incorporated by reference to Exhibit 3.2 to the registrant’s Registration Statement on Form S-1 filed with the SEC on August 6, 2008 (File No. 333-152830).)

3.2.2		Certificate of Amendment of Bylaws of Stevia First Corp. (Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the SEC on February 7, 2012.)

3.2.3		Bylaws of Malachite Innovations, Inc., effective as of November 10, 2021 (Incorporated by reference to Exhibit 3.2.3 to the registrant’s Quarterly Report on Form 10-Q filed with the SEC on November 15, 2021.)

10.10		Form of Common Stock Purchase Warrant (Incorporated by reference to Exhibit 10.10 to the registrant’s Registration Statement on Form S-1 filed with the SEC on August 31, 2021 (File No. 333-259010).

10.11#		Vitality Biopharma, Inc. 2021 Stock Incentive Plan (Incorporated by reference to Exhibit 99.1 to the registrant’s Registration Statement on Form S-8 filed with the SEC on September 3, 2021.)

10.12		Amended and Restated Revolving Promissory Note, dated as December 4, 2023, made by the Company, in favor of Independence Bank in the amount of $1,000,000 (Incorporated by reference to Exhibit 10.12 to the registrant’s Form 10-K/A filed with the SEC on August 8, 2024.)

10.13		Revolving Collateral Note, dated as June 16, 2023, made by Range Environmental Resources, Inc. and Range Natural Resources, Inc., in favor of Independence Bank in the amount of $1,000,000. (Incorporated by reference to Exhibit 10.13 to the registrant’s Form 10-K/A filed with the SEC on August 8, 2024.)

10.14		Secured Promissory Note, dated August 31, 2023, made by Collins Building and Contracting, Inc., in favor or Roger Collins in the principal amount of $2,035,250. (Incorporated by reference to Exhibit 10.14 to the registrant’s Form 10-K/A filed with the SEC on August 8, 2024.)

10.15		Secured Promissory Note, dated August 31, 2023, made by Collins Building and Contracting, Inc., in favor or Roger Collins in the principal amount of $2,000,000 (Incorporated by reference to Exhibit 10.15 to the registrant’s Form 10-K/A filed with the SEC on August 8, 2024.)

31.1		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934*

31.2		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934*

32.1		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002†

32.2		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002†

101.INS		Inline XBRL Instance Document *

101.SCH		Inline XBRL Taxonomy Extension Schema Document *

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase *

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document *

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document *

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document *

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

† Furnished herewith.

* Filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

RANGE IMPACT, INC.

By:	/s/ Michael Cavanaugh
	Michael Cavanaugh
	Chief Executive Officer
	(Principal Executive Officer)

Date:	August 14, 2024

By:	/s/ Patricia Missal
	Patricia Missal
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

Date:	August 14, 2024

EXHIBIT INDEX

Exhibit Number		Description of Exhibit

2.1		Agreement and Plan of Merger, dated September 14, 2011, by and between Stevia First Corp. and Legend Mining Inc. (Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the SEC on October 14, 2011.)

3.1.1		Articles of Incorporation of Stevia First Corp. (Incorporated by reference to Exhibit 3.1 to the registrant’s Registration Statement on Form S-1 filed with the SEC on August 6, 2008 (File No. 333-152830).)

3.1.2		Certificate of Amendment of Articles of Incorporation of Vitality Biopharma, Inc. (Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the SEC on July 19, 2016.)

3.1.3		Articles of Merger, effective October 10, 2011 (Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the SEC on October 14, 2011.)

3.1.4		Certificate of Change, effective October 10, 2011 (Incorporated by reference to Exhibit 3.2 to the registrant’s Current Report on Form 8-K filed with the SEC on October 14, 2011.)

3.2.1		Bylaws of Stevia First Corp. (Incorporated by reference to Exhibit 3.2 to the registrant’s Registration Statement on Form S-1 filed with the SEC on August 6, 2008 (File No. 333-152830).)

3.2.2		Certificate of Amendment of Bylaws of Stevia First Corp. (Incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the SEC on February 7, 2012.)

3.2.3		Bylaws of Malachite Innovations, Inc., effective as of November 10, 2021 (Incorporated by reference to Exhibit 3.2.3 to the registrant’s Quarterly Report on Form 10-Q filed with the SEC on November 15, 2021.)

10.10		Form of Common Stock Purchase Warrant (Incorporated by reference to Exhibit 10.10 to the registrant’s Registration Statement on Form S-1 filed with the SEC on August 31, 2021 (File No. 333-259010).

10.11#		Vitality Biopharma, Inc. 2021 Stock Incentive Plan (Incorporated by reference to Exhibit 99.1 to the registrant’s Registration Statement on Form S-8 filed with the SEC on September 3, 2021.)

10.12		Amended and Restated Revolving Promissory Note, dated as December 4, 2023, made by the Company, in favor of Independence Bank in the amount of $1,000,000 (Incorporated by reference to Exhibit 10.12 to the registrant’s Form 10-K/A filed with the SEC on August 8, 2024.)

10.13		Revolving Collateral Note, dated as June 16, 2023, made by Range Environmental Resources, Inc. and Range Natural Resources, Inc., in favor of Independence Bank in the amount of $1,000,000 (Incorporated by reference to Exhibit 10.13 to the registrant’s Form 10-K/A filed with the SEC on August 8, 2024.)

10.14		Secured Promissory Note, dated August 31, 2023, made by Collins Building and Contracting, Inc., in favor or Roger Collins in the principal amount of $2,035,250 (Incorporated by reference to Exhibit 10.14 to the registrant’s Form 10-K/A filed with the SEC on August 8, 2024.)

10.15		Secured Promissory Note, dated August 31, 2023, made by Collins Building and Contracting, Inc., in favor or Roger Collins in the principal amount of $2,000,000 (Incorporated by reference to Exhibit 10.15 to the registrant’s Form 10-K/A filed with the SEC on August 8, 2024.)

31.1		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934*

31.2		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934*

32.1		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002†

32.2		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002†

101.INS		Inline XBRL Instance Document *

101.SCH		Inline XBRL Taxonomy Extension Schema Document *

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase *

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document *

101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document *

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document *

104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

† Furnished herewith.

* Filed herewith

Exhibit 31.1

CERTIFICATION

I, Michael Cavanaugh, certify that:

	1.	I have reviewed this report on Form 10-Q for the quarterly period ended June 30, 2024 of Range Impact, Inc.;

	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

	4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	(a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2024

Name:	/s/ Michael Cavanaugh
By:	Michael Cavanaugh
Title:	Chief Executive Officer
	(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION

I, Patricia Missal, certify that:

	1.	I have reviewed this report on Form 10-Q for the quarterly period ended June 30, 2024 of Range Impact, Inc.;

	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

	4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

	(a)	all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2024

Name:	/s/ Patricia Missal
By:	Patricia Missal
Title:	Chief Financial Officer
	(Principal Financial and Accounting Officer)

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Michael Cavanaugh, the Chief Executive Officer of Range Impact, Inc. (the “Company”), hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q for the period ended June 30, 2024, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and that the information contained in the Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of the Company as of the dates and for the periods presented in the financial statements included in such report.

/s/ Michael Cavanaugh
Michael Cavanaugh
Chief Executive Officer
(Principal Executive Officer)

Date: August 14, 2024

This certification accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Exchange Act. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Patricia Missal, the Chief Financial Officer of Range Impact, Inc. (the “Company”), hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to her knowledge, the Quarterly Report on Form 10-Q for the period ended June 30, 2024, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and that the information contained in the Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of the Company as of the dates and for the periods presented in the financial statements included in such report.

/s/ Patricia Missal
Patricia Missal
Chief Financial Officer
(Principal Financial and Accounting Officer)

Date: August 14, 2024

Cover - $ / shares	6 Months Ended
Cover - $ / shares	Jun. 30, 2024	Aug. 13, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	000-53832
Entity Registrant Name	RANGE IMPACT, INC.
Entity Central Index Key	0001438943
Entity Tax Identification Number	75-3268988
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	200 Park Avenue
Entity Address, Address Line Two	Suite 400
Entity Address, City or Town	Cleveland
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44122
City Area Code	(216)
Local Phone Number	304-6556
Title of 12(b) Security	Common Stock
Trading Symbol	RNGE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		104,727,189
Entity Listing, Par Value Per Share	$ 0.001

Consolidated Balance Sheets - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 123,713	$ 2,176,800
Accounts receivable	4,388,785	7,185,411
Contract assets	1,374,962	247,310
Inventory	725,429
Prepaid expenses	42,204	115,324
Total current assets	6,655,093	9,724,845
Long-term Assets
Property and equipment, net of accumulated depreciation	12,025,030	13,301,902
Goodwill	751,421	751,421
Deposits	9,976	9,976
Total long-term assets	12,786,427	14,063,299
Total Assets	19,441,520	23,788,144
Current Liabilities
Accounts payable	2,036,868	3,714,014
Line of credit	2,200,000	2,400,000
Current portion of long-term debt	2,617,444	2,755,792
Deposits	150,000
Accrued expenses	54,402	101,283
Total current liabilities	7,058,714	8,971,089
Long-term Liabilities
Long-term debt, net of current portion	4,198,819	5,250,027
Total long-term debt	4,198,819	5,250,027
Total liabilities	11,257,533	14,221,116
Stockholders’ Equity
Common stock, par value $0.001 per share; 1,000,000,000 shares authorized; 104,727,189 and 101,023,485 shares issued and outstanding, respectively	104,727	101,023
Additional paid-in-capital	57,600,580	56,547,804
Accumulated deficit	(49,521,320)	(47,081,799)
Total stockholders’ equity	8,183,987	9,567,028
Total Liabilities and Stockholders’ Equity	$ 19,441,520	$ 23,788,144

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	104,727,189	101,023,485
Common stock, shares outstanding	104,727,189	101,023,485

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Revenues	$ 2,349,738	$ 3,998,267	$ 6,259,631	$ 7,013,154
Cost of services	2,498,667	3,153,166	6,389,706	5,519,051
Gross profit (loss)	(148,929)	845,101	(130,075)	1,494,103
Operating expenses:
General and administrative	697,699	635,898	1,641,600	1,361,946
Research and development	157,278	107,444	288,918	213,621
Total operating expenses	854,977	743,342	1,930,518	1,575,567
Profit (loss) from operations	(1,003,906)	101,759	(2,060,593)	(81,464)
Other income (expense):
Other income	485		18,590
Interest expense	(165,660)	(64,997)	(340,918)	(108,634)
Total other income (expense)	(165,175)	(64,997)	(322,328)	(108,634)
Income tax expense	56,600		56,600
Net loss	$ (1,225,681)	$ 36,762	$ (2,439,521)	$ (190,098)
Net loss per share - basic	$ (0.01)	$ 0.00	$ (0.02)	$ (0.00)
Net loss per share - diluted	$ (0.01)	$ 0.00	$ (0.02)	$ (0.00)
Weighted average number of common shares outstanding - basic	101,552,586	80,519,745	101,288,035	79,324,917
Weighted average number of common shares outstanding - diluted	101,552,586	80,519,745	101,288,035	79,324,917

Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2022	$ 78,117	$ 53,074,180	$ (50,212,854)	$ 2,939,443
Balance, shares at Dec. 31, 2022	78,116,814
Shares issued for cash	$ 2,733	407,267		410,000
Shares issued for cash, shares	2,733,334
Net income (loss)			(190,098)	(190,098)
Fair value of vested stock options		35,920		35,920
Balance at Jun. 30, 2023	$ 80,850	53,517,367	(50,402,952)	3,195,265
Balance, shares at Jun. 30, 2023	80,850,148
Balance at Mar. 31, 2023	$ 78,117	53,074,180	(50,439,714)	2,712,583
Balance, shares at Mar. 31, 2023	78,116,814
Shares issued for cash	$ 2,733	407,267		410,000
Shares issued for cash, shares	2,733,334
Net income (loss)			36,762	36,762
Fair value of vested stock options		35,920		35,920
Balance at Jun. 30, 2023	$ 80,850	53,517,367	(50,402,952)	3,195,265
Balance, shares at Jun. 30, 2023	80,850,148
Balance at Dec. 31, 2023	$ 101,023	56,547,804	(47,081,799)	9,567,028
Balance, shares at Dec. 31, 2023	101,023,485
Shares issued for cash	$ 3,704	996,296		1,000,000
Shares issued for cash, shares	3,703,704
Stock based compensation		56,480		56,480
Net income (loss)			(2,439,521)	(2,439,521)
Balance at Jun. 30, 2024	$ 104,727	57,600,580	(49,521,320)	8,183,987
Balance, shares at Jun. 30, 2024	104,727,189
Balance at Mar. 31, 2024	$ 101,023	56,552,294	(48,295,639)	8,357,678
Balance, shares at Mar. 31, 2024	101,023,485
Shares issued for cash	$ 3,704	996,296		1,000,000
Shares issued for cash, shares	3,703,704
Stock based compensation		51,990		51,990
Net income (loss)			(1,225,681)	(1,225,681)
Balance at Jun. 30, 2024	$ 104,727	$ 57,600,580	$ (49,521,320)	$ 8,183,987
Balance, shares at Jun. 30, 2024	104,727,189

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net loss	$ (2,439,521)	$ (190,098)
Adjustments to reconcile net loss to net cash (used in) operating activities:
Fair value of vested stock options	56,480	35,920
Depreciation	1,276,872	695,910
Changes in operating assets and liabilities:
Accounts receivable	2,796,626	(1,421,296)
Contract assets	(1,127,652)
Inventory	(725,429)
Prepaid expenses and other current assets	73,121	(46,835)
Accounts payable	(1,677,147)	539,084
Deposits	150,000
Accrued expenses	(46,881)
Deposits		(11,084)
Net cash (used in) operating activities	(1,663,531)	(398,399)
Cash flows from investing activities:
Equipment purchases		(784,515)
Net cash provided by (used in) investing activities		(784,515)
Cash flows from financing activities:
Issuance of shares for cash	1,000,000	410,000
Proceeds from long-term debt		383,202
Repayment of long-term debt	(1,189,556)	(893,093)
Proceeds from (repayment of) line of credit	(200,000)	1,200,000
Net cash provided by (used in) financing activities	(389,556)	1,100,109
Net decrease in cash and cash equivalents	(2,053,087)	(82,805)
Cash and cash equivalents - beginning of period	2,176,800	442,369
Cash and cash equivalents - end of period	123,713	359,564
Supplemental disclosure of cash flow information:
Interest	$ 251,348	$ 108,634

BUSINESS OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

BUSINESS OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

1. BUSINESS OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Range Impact, Inc. (the “Company”, “we”, “us”, or “our”), was incorporated in the State of Nevada on June 29, 2007.

Basis of Presentation

Use of Estimates

Business Combinations

Revenue Recognition

Contract Estimates

Contract Modifications

Cost and Expense Recognition

Revenue earned over time compared to a point in time is as follows for the three and six months ended June 30, 2024 and 2023.

	Three Months Ended June 30, 2024		Three Months Ended June 30, 2023

Earned over time	$	1,179,341	$	-
Point in time		1,170,397		3,998,267
Total revenue		2,349,738		3,998,267

	Six Months Ended June 30, 2024		Six Months Ended June 30, 2023

Earned over time	$	2,049,835	$	-
Point in time		4,209,796		7,013,154
Total revenue		6,259,631		7,013,154

Cost of Services

Cash and Cash Equivalents

Accounts Receivable

Contract Assets

Details of contract assets arising from reclamation contracts in process as of June 30, 2024 and December 31, 2023 are as follows:

SCHEDULE OF CONTRACT ASSETS

	June 30, 2024			December 31, 2023
Costs incurred on contracts in progress	$	1,623,680		$	425,634
Estimated earnings		1,192,317			340,528
Revenue earned on contracts in progress		2,815,997			766,162
Less: Billings to date		(1,441,035	)		(518,852	)
Total contract assets	$	1,374,962		$	247,310

Inventory

SCHEDULE OF INVENTORY

	June 30, 2024		December 31, 2023
Saleable coal inventory	$	725,429	$	-
Total coal inventory	$	725,429	$	-

Property & Equipment

SCHEDULE OF PROPERTY AND EQUIPMENT

	June 30, 2024			December 31, 2023

Equipment	$	13,835,929		$	13,835,929
Land		1,563,797			1,563,797
Buildings		199,500			199,500
Property and equipment, gross
Accumulated depreciation		(3,574,196	)		(2,297,324	)
Net book value		12,025,030			13,301,902
Depreciation expense	$	1,276,872		$	1,781,573

Land

Delivery Costs

Delivery costs are classified as cost of sales.

Goodwill

Income Taxes

Leases

Stock-Based Compensation

Basic and Diluted Income (Loss) Per Share

	June 30, 2024		December 31, 2023
Options		11,619,210		11,392,544
Warrants		3,313,335		3,313,335
Total		14,932,545		14,705,879
Anti-dilutive loss per share		14,932,545		14,705,879

Patents and Patent Application Costs

Research and Development

Fair Value of Financial Instruments

Segments

Recent Accounting Pronouncements

ACQUISITION OF COLLINS BUILDING & CONTRACTING

6 Months Ended

Jun. 30, 2024

Collins Building And Contracting [Member]

Business Acquisition [Line Items]

ACQUISITION OF COLLINS BUILDING & CONTRACTING

2. ACQUISITION OF COLLINS BUILDING & CONTRACTING

Fair value of assets acquired:
Equipment	$	6,156,000
Land		554,900
Buildings		199,500
Total assets acquired		6,910,400
Less: Gain on bargain purchase price		(1,875,150	)
Purchase price	$	5,035,250
Cash consideration		1,000,000
Long-term notes issued to the seller		4,035,250
Total purchase price	$	5,035,250
Acquisition transaction costs incurred	$	167,212

GOODWILL

6 Months Ended

Jun. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL

3. GOODWILL

SCHEDULE OF GOODWILL

	June 30, 2024		December 31, 2023
Environmental Services:
Beginning Balance	$	751,421	$	751,421
Acquisitions		-		-
Adjustments		-		-
Ending Balance	$	751,421	$	751,421

STOCK OPTIONS

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

STOCK OPTIONS

4. STOCK OPTIONS

Stock options issued during the three months ended June 30, 2024 and the three months ended June 30, 2023

A summary of the Company’s stock option activity during the six months ended June 30, 2024 is as follows:

SUMMARY OF STOCK OPTION ACTIVITY

	Shares			Weighted Average Exercise Price
Balance outstanding at December 31, 2023		11,392,544		$	0.47
Granted		250,000			0.38
Exchanged		-			-
Exercised		-			-
Expired		(23,334	)		4.09
Forfeited		-			-
Balance outstanding at June 30, 2024		11,619,210		$	0.45
Balance exercisable at June 30, 2024		11,394,210		$	0.46

At June 30, 2024, the 11,619,210 outstanding stock options had $875,480 of intrinsic value.

A summary of the Company’s stock options outstanding as of June 30, 2024 is as follows:

SCHEDULE OF STOCK OPTION OUTSTANDING

	Number of Options		Weighted Average Exercise Price		Weighted Average Grant- Date Stock Price
Options Outstanding, June 30, 2024		100,000	$	0.1337	$	0.1337
		3,050,000	$	0.18	$	0.18
		1,550,000	$	0.212	$	0.212
		1,150,000	$	0.277	$	0.277
		750,000	$	0.30	$	0.30
		2,000,000	$	0.35	$	0.35
		250,000	$	0.38	$	0.38
		1,664,542	$	0.50	$	0.50
		128,000	$	0.96	$	0.96
		350,834	$	1.50 - 1.95	$	1.50 - 1.95
		597,500	$	2.00 - 2.79	$	2.00 - 2.79
		28,334	$	3.10 - 3.50	$	3.10 - 3.50
		11,619,210

A summary of the Company’s stock options outstanding and exercisable as of June 30, 2024 is as follows:

	Number of Options		Weighted Average Exercise Price		Weighted Average Grant- Date Stock Price
Options Outstanding and Exercisable, June 30, 2024		100,000	$	0.1337	$	0.1337
		2,950,000	$	0.18	$	0.18
		1,550,000	$	0.212	$	0.212
		1,150,000	$	0.277	$	0.277
		750,000	$	0.30	$	0.30
		2,000,000	$	0.35	$	0.35
		125,000	$	0.38	$	0.38
		1,664,542	$	0.50	$	0.50
		128,000	$	0.96	$	0.96
		350,834	$	1.50 - 1.95	$	1.50 - 1.95
		597,500	$	2.00 - 2.79	$	2.00 - 2.79
		28,334	$	3.10 - 3.50	$	3.10 - 3.50
		11,394,210

WARRANTS

6 Months Ended

Jun. 30, 2024

Warrants

WARRANTS

5. WARRANTS

A summary of warrants to purchase common stock issued during the six months ended June 30, 2024 is as follows:

SCHEDULE OF WARRANTS ACTIVITY

	Shares		Weighted Average Exercise Price
Balance outstanding and exercisable at December 31, 2023		3,313,335	$	0.66
Granted		-		-
Exercised		-		-
Expired		-		-
Balance outstanding and exercisable at June 30, 2024		3,313,335	$	0.66

At June 30, 2024, the 3,313,335 outstanding stock warrants had $15,000 of intrinsic value.

NOTES PAYABLE

6 Months Ended

Jun. 30, 2024

Debt Disclosure [Abstract]

NOTES PAYABLE

6. NOTES PAYABLE

The Company had no notes payable outstanding as of June 30, 2024, or December 31, 2023.

LINE OF CREDIT

6 Months Ended

Jun. 30, 2024

Line Of Credit

LINE OF CREDIT

7. LINE OF CREDIT

LONG-TERM DEBT OBLIGATIONS

6 Months Ended

Jun. 30, 2024

Debt Disclosure [Abstract]

LONG-TERM DEBT OBLIGATIONS

8. LONG-TERM DEBT OBLIGATIONS

Long-term debt consists of debt on vehicles and equipment, which serves as the collateral, and debt issued as part of the acquisition of Collins Building.

Interest rates on the equipment financings range from 3.69% to 9.95% for 2024 and mature between 2025 through 2029.

A summary of payments due under the long-term debt by year is as follows:

	Equipment Financing		Collins Promissory Notes

2024 – due between July 1, 2024 and June 30, 2025	$	1,206,455	$	1,410,989
2025 – due between July 1, 2025 and June 30, 2026		869,454		576,105
2026 – due between July 1, 2026 and June 30, 2027		791,242		422,587
2027 – due between July 1, 2027 and June 30, 2028		644,147		452,644
2028 and later – due on July 1, 2028 and thereafter		364,129		78,511
Total long-term debt	$	3,875,427	$	2,940,836

MAJOR CUSTOMER AND CONCENTRATION OF CREDIT RISK

6 Months Ended

Jun. 30, 2024

Risks and Uncertainties [Abstract]

MAJOR CUSTOMER AND CONCENTRATION OF CREDIT RISK

9. MAJOR CUSTOMER AND CONCENTRATION OF CREDIT RISK

Accounts receivable from the same customers were 99% of total accounts receivable as of June 30, 2024 and 70% as of December 31, 2023.

EARNINGS PER COMMON SHARE

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

EARNINGS PER COMMON SHARE

10. EARNINGS PER COMMON SHARE

The following table sets forth the computation of basic and diluted earnings per share.


	Three Months Ended June 30,					Six Months Ended June 30,
	2024			2023		2024			2023
Earnings Per Share - Basic
Net (loss)/income	$	(1,225,681	)	$	36,762	$	(2,439,521	)	$	(190,098	)
Weighted average shares of common stock outstanding - Basic		101,552,586			80,519,745		101,288,035			79,324,917
Earnings Per Share - Basic	$	(0.01	)	$	0.00	$	(0.02	)	$	(0.00	)

Earnings Per Share - Diluted
Weighted average shares of common stock outstanding - Basic		101,552,586			80,519,745		101,288,035			79,324,917
Unvested Restricted Stock Awards		-			-		-			-
Weighted average shares of common stock - Diluted		101,552,586			80,519,745		101,288,035			79,324,917
Earnings Per Share - Diluted	$	(0.01	)	$	0.00	$	(0.02	)	$	(0.00	)

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Jun. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

11. COMMITMENTS AND CONTINGENCIES

SEGMENT INFORMATION

6 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

SEGMENT INFORMATION

12. SEGMENT INFORMATION

The six reportable segments that result from applying the aggregation criteria are as follows:

●	Range Reclaim – land reclamation, water restoration and land repurposing

●	Range Minerals – subcontracted mining and reclamation activities

●	Range Water – biochar product development and water solutions business

●	Range Security – security services on mine land being reclaimed and repurposed for non-fossil fuel uses

●	Range Land – mine land being acquired, reclaimed and repurposed for non-fossil fuel uses

●	Graphium Biosciences – glycosylated cannabinoid drug development program

The Company had no inter-segment sales for the periods presented.

Summarized financial information concerning the Company’s reportable segments is shown as below:

By Categories


	For the Three Months Ended June 30, 2024
	Range Reclaim			Range Minerals			Range Water			Range Security		Range Land		Graphium Biosciences			Corporate			Total

Sales	$	2,050,958		$	138,118		$	-			160,662	$	-	$	-		$	-		$	2,349,738
Gross profit		(252,848	)		20,842			-			83,077		-		-			-			(148,929	)
Net income (loss)		(579,928	)		(84,121	)		(5,154	)		57,302		-		(157,275	)		(456,505	)		(1,225,681	)

Total assets		12,966,495			4,453,028			12,579			226,846		1,008,940		9,147			764,485			19,441,520
Depreciation		634,906			-			639			2,892		-		-			-			638,437
Interest expense		61,195			-			-			-		-		-			104,465			165,660
Tax expense		-						-			-		-		-			56,600			56,600
Capital expenditures for long-lived assets	$	-		$	-		$	-			-	$	-	$	-		$	-		$	-


	For the Three Months Ended June 30, 2023
	Range Reclaim		Range Water			Range Security		Range Land		Graphium Biosciences			Corporate			Total

Sales	$	3,882,492	$	-		$	115,775	$	-	$	-		$	-		$	3,998,267
Gross profit		789,687		-			55,414		-		-			-			845,101
Net income (loss)		433,922		(19,116	)		37,550		-		(107,444	)		(308,150	)		36,762

Total assets		9,440,020		15,138			94,610		-		8,784			156,928			9,715,480
Depreciation		338,409		426			2,891		-		-			-			341,726
Interest expense		63,061		-			224		-		-			1,712			64,997
Tax expense		-		-			-		-		-			-			-
Capital expenditures for long-lived assets	$	38,289	$	-		$	-	$	-	$	-		$	-		$	38,289


	For the Six Months Ended June 30, 2024
	Range Reclaim			Range Minerals		Range Water			Range Security		Range Land		Graphium Biosciences			Corporate			Total

Sales	$	3,556,941		$	2,120,233	$	-		$	582,457	$	-	$	-		$	-		$	6,259,631
Gross profit		(832,531	)		357,654		-			344,802		-		-			-			(130,075	)
Net income (loss)		(1,626,300	)		152,455		(38,736	)		289,542		-		(288,915	)		(927,567	)		(2,439,521	)

Total assets		12,966,495			4,453,028		12,579			226,846		1,008,940		9,147			764,485			19,441,520
Depreciation		1,269,811			-		1,279			5,782		-		-			-			1,276,872
Interest expense		154,173			-		-			-		-		-			186,745			340,918
Tax expense		-					-			-		-		-			56,600			56,600
Capital expenditures for long-lived assets	$	-		$	-	$	-		$	-	$	-	$	-		$	-		$	-


	For the Six Months Ended June 30, 2023
	Range Reclaim		Range Water			Range Security		Range Land		Graphium Biosciences			Corporate			Total

Sales	$	6,870,979	$	-		$	142,175	$	-	$	-		$	-		$	7,013,154
Gross profit		1,428,266		-			65,837		-		-			-			1,494,103
Net income (loss)		620,565		(38,280	)		20,445		-		(213,621	)		(579,207	)		(190,098	)

Total assets		9,440,020		15,138			94,610		-		8,784			156,928			9,715,480
Depreciation		691,165		426			4,319		-		-			-			695,910
Interest expense		105,811		-			224		-		-			2,599			108,634
Tax expense		-		-			-		-		-			-			-
Capital expenditures for long-lived assets	$	716,491	$	15,350		$	52,674	$	-	$	-		$	-		$	784,515

SUBSEQUENT EVENTS

6 Months Ended

Jun. 30, 2024

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

13. SUBSEQUENT EVENTS

None.

BUSINESS OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

Basis of Presentation

Use of Estimates

Business Combinations

Revenue Recognition

Contract Estimates

Contract Modifications

Cost and Expense Recognition

Revenue earned over time compared to a point in time is as follows for the three and six months ended June 30, 2024 and 2023.

	Three Months Ended June 30, 2024		Three Months Ended June 30, 2023

Earned over time	$	1,179,341	$	-
Point in time		1,170,397		3,998,267
Total revenue		2,349,738		3,998,267

	Six Months Ended June 30, 2024		Six Months Ended June 30, 2023

Earned over time	$	2,049,835	$	-
Point in time		4,209,796		7,013,154
Total revenue		6,259,631		7,013,154

Cost of Services

Cash and Cash Equivalents

Accounts Receivable

Contract Assets

Details of contract assets arising from reclamation contracts in process as of June 30, 2024 and December 31, 2023 are as follows:

SCHEDULE OF CONTRACT ASSETS

	June 30, 2024			December 31, 2023
Costs incurred on contracts in progress	$	1,623,680		$	425,634
Estimated earnings		1,192,317			340,528
Revenue earned on contracts in progress		2,815,997			766,162
Less: Billings to date		(1,441,035	)		(518,852	)
Total contract assets	$	1,374,962		$	247,310

Inventory

SCHEDULE OF INVENTORY

	June 30, 2024		December 31, 2023
Saleable coal inventory	$	725,429	$	-
Total coal inventory	$	725,429	$	-

Property & Equipment

SCHEDULE OF PROPERTY AND EQUIPMENT

	June 30, 2024			December 31, 2023

Equipment	$	13,835,929		$	13,835,929
Land		1,563,797			1,563,797
Buildings		199,500			199,500
Property and equipment, gross
Accumulated depreciation		(3,574,196	)		(2,297,324	)
Net book value		12,025,030			13,301,902
Depreciation expense	$	1,276,872		$	1,781,573

Land

Delivery Costs

Delivery costs are classified as cost of sales.

Goodwill

Income Taxes

Leases

Stock-Based Compensation

Basic and Diluted Income (Loss) Per Share

	June 30, 2024		December 31, 2023
Options		11,619,210		11,392,544
Warrants		3,313,335		3,313,335
Total		14,932,545		14,705,879
Anti-dilutive loss per share		14,932,545		14,705,879

Patents and Patent Application Costs

Research and Development

Fair Value of Financial Instruments

Segments

Recent Accounting Pronouncements

BUSINESS OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

SCHEDULE OF REVENUE EARNED OVERTIME COMPARED TO A POINT IN TIME

Revenue earned over time compared to a point in time is as follows for the three and six months ended June 30, 2024 and 2023.

	Three Months Ended June 30, 2024		Three Months Ended June 30, 2023

Earned over time	$	1,179,341	$	-
Point in time		1,170,397		3,998,267
Total revenue		2,349,738		3,998,267

	Six Months Ended June 30, 2024		Six Months Ended June 30, 2023

Earned over time	$	2,049,835	$	-
Point in time		4,209,796		7,013,154
Total revenue		6,259,631		7,013,154

SCHEDULE OF CONTRACT ASSETS

Details of contract assets arising from reclamation contracts in process as of June 30, 2024 and December 31, 2023 are as follows:

SCHEDULE OF CONTRACT ASSETS

	June 30, 2024			December 31, 2023
Costs incurred on contracts in progress	$	1,623,680		$	425,634
Estimated earnings		1,192,317			340,528
Revenue earned on contracts in progress		2,815,997			766,162
Less: Billings to date		(1,441,035	)		(518,852	)
Total contract assets	$	1,374,962		$	247,310

SCHEDULE OF INVENTORY

	June 30, 2024		December 31, 2023
Saleable coal inventory	$	725,429	$	-
Total coal inventory	$	725,429	$	-

SCHEDULE OF PROPERTY AND EQUIPMENT

	June 30, 2024			December 31, 2023

Equipment	$	13,835,929		$	13,835,929
Land		1,563,797			1,563,797
Buildings		199,500			199,500
Property and equipment, gross
Accumulated depreciation		(3,574,196	)		(2,297,324	)
Net book value		12,025,030			13,301,902
Depreciation expense	$	1,276,872		$	1,781,573

SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

	June 30, 2024		December 31, 2023
Options		11,619,210		11,392,544
Warrants		3,313,335		3,313,335
Total		14,932,545		14,705,879
Anti-dilutive loss per share		14,932,545		14,705,879

ACQUISITION OF COLLINS BUILDING & CONTRACTING (Tables)

6 Months Ended

Jun. 30, 2024

Collins Building And Contracting [Member]

Business Acquisition [Line Items]

SCHEDULE OF BUSINESS ACQUISITION ALLOCATION OF PURCHASE PRICE

Fair value of assets acquired:
Equipment	$	6,156,000
Land		554,900
Buildings		199,500
Total assets acquired		6,910,400
Less: Gain on bargain purchase price		(1,875,150	)
Purchase price	$	5,035,250
Cash consideration		1,000,000
Long-term notes issued to the seller		4,035,250
Total purchase price	$	5,035,250
Acquisition transaction costs incurred	$	167,212

GOODWILL (Tables)

6 Months Ended

Jun. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

SCHEDULE OF GOODWILL

	June 30, 2024		December 31, 2023
Environmental Services:
Beginning Balance	$	751,421	$	751,421
Acquisitions		-		-
Adjustments		-		-
Ending Balance	$	751,421	$	751,421

STOCK OPTIONS (Tables)

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

SUMMARY OF STOCK OPTION ACTIVITY

A summary of the Company’s stock option activity during the six months ended June 30, 2024 is as follows:

SUMMARY OF STOCK OPTION ACTIVITY

	Shares			Weighted Average Exercise Price
Balance outstanding at December 31, 2023		11,392,544		$	0.47
Granted		250,000			0.38
Exchanged		-			-
Exercised		-			-
Expired		(23,334	)		4.09
Forfeited		-			-
Balance outstanding at June 30, 2024		11,619,210		$	0.45
Balance exercisable at June 30, 2024		11,394,210		$	0.46

SCHEDULE OF STOCK OPTION OUTSTANDING

A summary of the Company’s stock options outstanding as of June 30, 2024 is as follows:

SCHEDULE OF STOCK OPTION OUTSTANDING

	Number of Options		Weighted Average Exercise Price		Weighted Average Grant- Date Stock Price
Options Outstanding, June 30, 2024		100,000	$	0.1337	$	0.1337
		3,050,000	$	0.18	$	0.18
		1,550,000	$	0.212	$	0.212
		1,150,000	$	0.277	$	0.277
		750,000	$	0.30	$	0.30
		2,000,000	$	0.35	$	0.35
		250,000	$	0.38	$	0.38
		1,664,542	$	0.50	$	0.50
		128,000	$	0.96	$	0.96
		350,834	$	1.50 - 1.95	$	1.50 - 1.95
		597,500	$	2.00 - 2.79	$	2.00 - 2.79
		28,334	$	3.10 - 3.50	$	3.10 - 3.50
		11,619,210

SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE

A summary of the Company’s stock options outstanding and exercisable as of June 30, 2024 is as follows:

	Number of Options		Weighted Average Exercise Price		Weighted Average Grant- Date Stock Price
Options Outstanding and Exercisable, June 30, 2024		100,000	$	0.1337	$	0.1337
		2,950,000	$	0.18	$	0.18
		1,550,000	$	0.212	$	0.212
		1,150,000	$	0.277	$	0.277
		750,000	$	0.30	$	0.30
		2,000,000	$	0.35	$	0.35
		125,000	$	0.38	$	0.38
		1,664,542	$	0.50	$	0.50
		128,000	$	0.96	$	0.96
		350,834	$	1.50 - 1.95	$	1.50 - 1.95
		597,500	$	2.00 - 2.79	$	2.00 - 2.79
		28,334	$	3.10 - 3.50	$	3.10 - 3.50
		11,394,210

WARRANTS (Tables)

6 Months Ended

Jun. 30, 2024

Warrants

SCHEDULE OF WARRANTS ACTIVITY

A summary of warrants to purchase common stock issued during the six months ended June 30, 2024 is as follows:

SCHEDULE OF WARRANTS ACTIVITY

	Shares		Weighted Average Exercise Price
Balance outstanding and exercisable at December 31, 2023		3,313,335	$	0.66
Granted		-		-
Exercised		-		-
Expired		-		-
Balance outstanding and exercisable at June 30, 2024		3,313,335	$	0.66

LONG-TERM DEBT OBLIGATIONS (Tables)

6 Months Ended

Jun. 30, 2024

Debt Disclosure [Abstract]

SCHEDULE OF MATURITIES OF LONG TERM DEBT

A summary of payments due under the long-term debt by year is as follows:

	Equipment Financing		Collins Promissory Notes

2024 – due between July 1, 2024 and June 30, 2025	$	1,206,455	$	1,410,989
2025 – due between July 1, 2025 and June 30, 2026		869,454		576,105
2026 – due between July 1, 2026 and June 30, 2027		791,242		422,587
2027 – due between July 1, 2027 and June 30, 2028		644,147		452,644
2028 and later – due on July 1, 2028 and thereafter		364,129		78,511
Total long-term debt	$	3,875,427	$	2,940,836

EARNINGS PER COMMON SHARE (Tables)

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

SCHEDULE OF BASIC AND DILUTED EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share.


	Three Months Ended June 30,					Six Months Ended June 30,
	2024			2023		2024			2023
Earnings Per Share - Basic
Net (loss)/income	$	(1,225,681	)	$	36,762	$	(2,439,521	)	$	(190,098	)
Weighted average shares of common stock outstanding - Basic		101,552,586			80,519,745		101,288,035			79,324,917
Earnings Per Share - Basic	$	(0.01	)	$	0.00	$	(0.02	)	$	(0.00	)

Earnings Per Share - Diluted
Weighted average shares of common stock outstanding - Basic		101,552,586			80,519,745		101,288,035			79,324,917
Unvested Restricted Stock Awards		-			-		-			-
Weighted average shares of common stock - Diluted		101,552,586			80,519,745		101,288,035			79,324,917
Earnings Per Share - Diluted	$	(0.01	)	$	0.00	$	(0.02	)	$	(0.00	)

SEGMENT INFORMATION (Tables)

6 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

SCHEDULE OF FINANCIAL INFORMATION OF REPORTABLE SEGMENT

Summarized financial information concerning the Company’s reportable segments is shown as below:

By Categories


	For the Three Months Ended June 30, 2024
	Range Reclaim			Range Minerals			Range Water			Range Security		Range Land		Graphium Biosciences			Corporate			Total

Sales	$	2,050,958		$	138,118		$	-			160,662	$	-	$	-		$	-		$	2,349,738
Gross profit		(252,848	)		20,842			-			83,077		-		-			-			(148,929	)
Net income (loss)		(579,928	)		(84,121	)		(5,154	)		57,302		-		(157,275	)		(456,505	)		(1,225,681	)

Total assets		12,966,495			4,453,028			12,579			226,846		1,008,940		9,147			764,485			19,441,520
Depreciation		634,906			-			639			2,892		-		-			-			638,437
Interest expense		61,195			-			-			-		-		-			104,465			165,660
Tax expense		-						-			-		-		-			56,600			56,600
Capital expenditures for long-lived assets	$	-		$	-		$	-			-	$	-	$	-		$	-		$	-


	For the Three Months Ended June 30, 2023
	Range Reclaim		Range Water			Range Security		Range Land		Graphium Biosciences			Corporate			Total

Sales	$	3,882,492	$	-		$	115,775	$	-	$	-		$	-		$	3,998,267
Gross profit		789,687		-			55,414		-		-			-			845,101
Net income (loss)		433,922		(19,116	)		37,550		-		(107,444	)		(308,150	)		36,762

Total assets		9,440,020		15,138			94,610		-		8,784			156,928			9,715,480
Depreciation		338,409		426			2,891		-		-			-			341,726
Interest expense		63,061		-			224		-		-			1,712			64,997
Tax expense		-		-			-		-		-			-			-
Capital expenditures for long-lived assets	$	38,289	$	-		$	-	$	-	$	-		$	-		$	38,289


	For the Six Months Ended June 30, 2024
	Range Reclaim			Range Minerals		Range Water			Range Security		Range Land		Graphium Biosciences			Corporate			Total

Sales	$	3,556,941		$	2,120,233	$	-		$	582,457	$	-	$	-		$	-		$	6,259,631
Gross profit		(832,531	)		357,654		-			344,802		-		-			-			(130,075	)
Net income (loss)		(1,626,300	)		152,455		(38,736	)		289,542		-		(288,915	)		(927,567	)		(2,439,521	)

Total assets		12,966,495			4,453,028		12,579			226,846		1,008,940		9,147			764,485			19,441,520
Depreciation		1,269,811			-		1,279			5,782		-		-			-			1,276,872
Interest expense		154,173			-		-			-		-		-			186,745			340,918
Tax expense		-					-			-		-		-			56,600			56,600
Capital expenditures for long-lived assets	$	-		$	-	$	-		$	-	$	-	$	-		$	-		$	-


	For the Six Months Ended June 30, 2023
	Range Reclaim		Range Water			Range Security		Range Land		Graphium Biosciences			Corporate			Total

Sales	$	6,870,979	$	-		$	142,175	$	-	$	-		$	-		$	7,013,154
Gross profit		1,428,266		-			65,837		-		-			-			1,494,103
Net income (loss)		620,565		(38,280	)		20,445		-		(213,621	)		(579,207	)		(190,098	)

Total assets		9,440,020		15,138			94,610		-		8,784			156,928			9,715,480
Depreciation		691,165		426			4,319		-		-			-			695,910
Interest expense		105,811		-			224		-		-			2,599			108,634
Tax expense		-		-			-		-		-			-			-
Capital expenditures for long-lived assets	$	716,491	$	15,350		$	52,674	$	-	$	-		$	-		$	784,515

SCHEDULE OF REVENUE EARNED OVERTIME COMPARED TO A POINT IN TIME (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disaggregation of Revenue [Line Items]
Total revenue	$ 2,349,738	$ 3,998,267	$ 6,259,631	$ 7,013,154
Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Total revenue	1,179,341		2,049,835
Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,170,397	$ 3,998,267	$ 4,209,796	$ 7,013,154

SCHEDULE OF CONTRACT ASSETS (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Costs incurred on contracts in progress	$ 1,623,680	$ 425,634
Estimated earnings	1,192,317	340,528
Revenue earned on contracts in progress	2,815,997	766,162
Less: Billings to date	(1,441,035)	(518,852)
Total contract assets	$ 1,374,962	$ 247,310

SCHEDULE OF INVENTORY (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Saleable coal inventory	$ 725,429
Total coal inventory	$ 725,429

SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)	6 Months Ended	12 Months Ended
SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Accumulated depreciation	$ (3,574,196)	$ (2,297,324)
Net book value	12,025,030	13,301,902
Depreciation expense	1,276,872	1,781,573
Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	13,835,929	13,835,929
Land [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,563,797	1,563,797
Building [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 199,500	$ 199,500

SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive loss per share	14,932,545	14,705,879
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive loss per share	11,619,210	11,392,544
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive loss per share	3,313,335	3,313,335

BUSINESS OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	6 Months Ended
	Jun. 30, 2024 USD ($) Segment	Jun. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)
Accounting Policies [Abstract]
Contract receivables	$ 0		$ 2,100,255
Allowances for doubtful accounts receivable	0	$ 0
Accounts receivable	4,388,785		7,185,411
Bad debt expense	0	$ 0
Allowances for credit losses	0		0
Due from contractor	725,429
Inventory value	$ 725,429
Equipment estimated useful lives	6 years
Number of operating segments \| Segment	6

SCHEDULE OF BUSINESS ACQUISITION ALLOCATION OF PURCHASE PRICE (Details)	Aug. 31, 2023 USD ($)
Business Acquisition [Line Items]
Equipment	$ 6,156,000
Land	554,900
Buildings	199,500
Total assets acquired	6,910,400
Collins Building And Contracting [Member]
Business Acquisition [Line Items]
Less: Gain on bargain purchase price	(1,875,150)
Purchase price	5,035,250
Cash consideration	1,000,000
Total purchase price	5,035,250
Acquisition transaction costs incurred	167,212
Range Reclamation Entities [Member]
Business Acquisition [Line Items]
Long-term notes issued to the seller	$ 4,035,250

ACQUISITION OF COLLINS BUILDING & CONTRACTING (Details Narrative) - USD ($)		3 Months Ended		6 Months Ended
	Aug. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Business Acquisition [Line Items]
Net loss		$ (1,225,681)	$ 36,762	$ (2,439,521)	$ (190,098)
Collins Building And Contracting [Member]
Business Acquisition [Line Items]
Purchase gain recognized amount	$ 1,875,150
Revenues		0		0
Net loss		$ 274,081		$ 544,836
Separation Agreement [Member] \| Collins Building And Contracting [Member]
Business Acquisition [Line Items]
Agreement, description	(a) cash consideration of $1,000,000, (b) a five-year secured promissory note in the principal amount of $2,000,000, bearing interest at 7.0% per annum (the “First Promissory Note”), and (c) a two-year secured promissory note in the principal amount of $2,035,250, bearing interest at 8.25% per annum (the “Second Promissory Note”).

SCHEDULE OF GOODWILL (Details) - USD ($)	6 Months Ended	12 Months Ended
SCHEDULE OF GOODWILL (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Beginning Balance	$ 751,421	$ 751,421
Acquisitions
Adjustments
Ending Balance	$ 751,421	$ 751,421

GOODWILL (Details Narrative) - USD ($)	Jun. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 751,421	$ 751,421	$ 751,421

SUMMARY OF STOCK OPTION ACTIVITY (Details)	6 Months Ended
SUMMARY OF STOCK OPTION ACTIVITY (Details)	Jun. 30, 2024 $ / shares shares
Share-Based Payment Arrangement [Abstract]
Shares Outstanding, Balance \| shares	11,392,544
Weighted Average Exercise Price, Outstanding Balance \| $ / shares	$ 0.47
Shares, Granted \| shares	250,000
Weighted Average Exercise Price, Granted \| $ / shares	$ 0.38
Shares, Exchanged \| shares
Weighted Average Exercise Price, Exchanged \| $ / shares
Shares, Exercised \| shares
Weighted Average Exercise Price, Exercised \| $ / shares
Shares, Expired \| shares	(23,334)
Weighted Average Exercise Price, Expired \| $ / shares	$ 4.09
Shares, Forfeited \| shares
Weighted Average Exercise Price, Forfeited \| $ / shares
Shares Outstanding, Balance \| shares	11,619,210
Weighted Average Exercise Price, Outstanding Balance \| $ / shares	$ 0.45
Shares, Balance Exercisable \| shares	11,394,210
Weighted Average Exercise Price, Balance Exercisable \| $ / shares	$ 0.46

SCHEDULE OF STOCK OPTION OUTSTANDING (Details) - $ / shares	6 Months Ended
	Jun. 30, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	11,619,210	11,392,544
Weighted Average Exercise Price, Outstanding Balance	$ 0.45	$ 0.47
Stock Options One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	100,000
Weighted Average Exercise Price, Outstanding Balance	$ 0.1337
Weighted Average Exercise Price, Granted	$ 0.1337
Stock Options Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	3,050,000
Weighted Average Exercise Price, Outstanding Balance	$ 0.18
Weighted Average Exercise Price, Granted	$ 0.18
Stock Options Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	1,550,000
Weighted Average Exercise Price, Outstanding Balance	$ 0.212
Weighted Average Exercise Price, Granted	$ 0.212
Stock Options Four [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	1,150,000
Weighted Average Exercise Price, Outstanding Balance	$ 0.277
Weighted Average Exercise Price, Granted	$ 0.277
Stock Options Five [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	750,000
Weighted Average Exercise Price, Outstanding Balance	$ 0.30
Weighted Average Exercise Price, Granted	$ 0.30
Stock Options Six [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	2,000,000
Weighted Average Exercise Price, Outstanding Balance	$ 0.35
Weighted Average Exercise Price, Granted	$ 0.35
Stock Options Seven [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	250,000
Weighted Average Exercise Price, Outstanding Balance	$ 0.38
Weighted Average Exercise Price, Granted	$ 0.38
Stock Options Eight [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	1,664,542
Weighted Average Exercise Price, Outstanding Balance	$ 0.50
Weighted Average Exercise Price, Granted	$ 0.50
Stock Options Nine [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	128,000
Weighted Average Exercise Price, Outstanding Balance	$ 0.96
Weighted Average Exercise Price, Granted	$ 0.96
Stock Options Ten [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	350,834
Stock Options Ten [Member] \| Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Outstanding Balance	$ 1.50
Weighted Average Exercise Price, Granted	1.50
Stock Options Ten [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Outstanding Balance	1.95
Weighted Average Exercise Price, Granted	$ 1.95
Stock Options Eleven [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	597,500
Stock Options Eleven [Member] \| Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Outstanding Balance	$ 2.00
Weighted Average Exercise Price, Granted	2.00
Stock Options Eleven [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Outstanding Balance	2.79
Weighted Average Exercise Price, Granted	$ 2.79
Stock Options Twelve [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding balance	28,334
Stock Options Twelve [Member] \| Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Outstanding Balance	$ 3.10
Weighted Average Exercise Price, Granted	3.10
Stock Options Twelve [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Outstanding Balance	3.50
Weighted Average Exercise Price, Granted	$ 3.50

SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE (Details)	Jun. 30, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	11,394,210
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 0.46
Stock Options One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	100,000
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 0.1337
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	$ 0.1337
Stock Options Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	2,950,000
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 0.18
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	$ 0.18
Stock Options Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	1,550,000
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 0.212
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	$ 0.212
Stock Options Four [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	1,150,000
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 0.277
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	$ 0.277
Stock Options Five [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	750,000
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 0.30
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	$ 0.30
Stock Options Six [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	2,000,000
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 0.35
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	$ 0.35
Stock Options Seven [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	125,000
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 0.38
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	$ 0.38
Stock Options Eight [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	1,664,542
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 0.50
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	$ 0.50
Stock Options Nine [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	128,000
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 0.96
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	$ 0.96
Stock Options Ten [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	350,834
Stock Options Ten [Member] \| Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 1.50
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	1.50
Stock Options Ten [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Options Outstanding and exercisable	1.95
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	$ 1.95
Stock Options Eleven [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	597,500
Stock Options Eleven [Member] \| Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 2.00
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	2.00
Stock Options Eleven [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Options Outstanding and exercisable	2.79
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	$ 2.79
Stock Options Twelve [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Options Outstanding and exercisable \| shares	28,334
Stock Options Twelve [Member] \| Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Options Outstanding and exercisable	$ 3.10
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	3.10
Stock Options Twelve [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Options Outstanding and exercisable	3.50
Weighted Average Grant-date Stock Price, Options Outstanding and exercisable	$ 3.50

STOCK OPTIONS (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
STOCK OPTIONS (Details Narrative) - USD ($)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation arrangement by share based payment award options grants in period gross			250,000
Stock based compensation expense	$ 51,990	$ 35,920
Unamortized cost of outstanding stock-based awards	$ 60,970		$ 60,970
Stock options outstanding	11,619,210		11,619,210	11,392,544
Stock options, intrinsic value	$ 875,480		$ 875,480
Directors And Employees [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair value of the option grants to employees	$ 250,000	$ 400,000
Share based compensation arrangements by share based payment award options grants in period weighted average exercise price	$ 0.38	$ 0.18
Options expiration period	10 years	5 years
Share based compensation arrangement by share based payment award options grants in period gross	125,000	200,000
Volatility rate	267.24%
Discount rate	4.70%
Expected dividend yield	0.00%	0.00%
Expected life	10 years	5 years
Directors And Employees [Member] \| Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Volatility rate		273.24%
Discount rate		1.40%
Directors And Employees [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Volatility rate		273.87%
Discount rate		1.55%
Employees [Member] \| Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair value of the option grants to employees	$ 95,000	$ 71,840
Employees [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair value of the option grants to employees	$ 47,500	$ 35,920

SCHEDULE OF WARRANTS ACTIVITY (Details) - Warrant [Member]	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Number of Shares, Warrants Outstanding and Exercisable, Beginning Balance \| shares	3,313,335
Weighted Average Exercise Price, Warrants Outstanding and Exercisable, Beginning Balance \| $ / shares	$ 0.66
Number of Shares, Warrants Granted \| shares
Weighted Average Exercise Price, Warrants Outstanding, Granted \| $ / shares
Number of Shares, Warrants Exercised \| shares
Weighted Average Exercise Price, Warrants Outstanding, Exercised \| $ / shares
Number of Shares, Warrants Expired \| shares
Weighted Average Exercise Price, Warrants Outstanding, Expired \| $ / shares
Number of Shares, Warrants Outstanding and Exercisable Ending \| shares	3,313,335
Weighted Average Exercise Price, Warrants Outstanding, Outstanding and Exercisable, Ending Balance \| $ / shares	$ 0.66

WARRANTS (Details)	Jun. 30, 2024 USD ($) shares
Common Stock [Member]
Warrants outstanding \| shares	3,313,335
Warrant [Member]
Warrants intrinsic value \| $	$ 15,000

NOTES PAYABLE (Details Narrative) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
Notes payable outstanding	$ 0	$ 0

LINE OF CREDIT (Details Narrative) - USD ($)	1 Months Ended
LINE OF CREDIT (Details Narrative) - USD ($)	Nov. 30, 2023	Jun. 30, 2023	Nov. 30, 2022	Jun. 30, 2024	Dec. 31, 2023
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity			$ 1,000,000
Line of credit maturity date			Nov. 30, 2024
Bears interest percentage			1.00%
Line of credit facility interest rate description			prime rate plus one percent margin
Prime rate percentage				9.50%
Line of credit				$ 1,000,000	$ 1,000,000
Secured Debt [Member]
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity		$ 1,000,000
Line of credit maturity date		Dec. 31, 2024
Prime rate percentage				8.50%
Line of credit				$ 1,200,000	$ 1,400,000
Line of Credit Facility, Increase (Decrease), Net	$ 1,400,000

SCHEDULE OF MATURITIES OF LONG TERM DEBT (Details)	Jun. 30, 2024 USD ($)
Equipment Financing [Member]
Short-Term Debt [Line Items]
2024 – due between July 1, 2024 and June 30, 2025	$ 1,206,455
2025 – due between July 1, 2025 and June 30, 2026	869,454
2026 – due between July 1, 2026 and June 30, 2027	791,242
2027 – due between July 1, 2027 and June 30, 2028	644,147
2028 and later – due on July 1, 2028 and thereafter	364,129
Total long-term debt	3,875,427
Collins Promissory Notes [Member]
Short-Term Debt [Line Items]
2024 – due between July 1, 2024 and June 30, 2025	1,410,989
2025 – due between July 1, 2025 and June 30, 2026	576,105
2026 – due between July 1, 2026 and June 30, 2027	422,587
2027 – due between July 1, 2027 and June 30, 2028	452,644
2028 and later – due on July 1, 2028 and thereafter	78,511
Total long-term debt	$ 2,940,836

LONG-TERM DEBT OBLIGATIONS (Details Narrative)	6 Months Ended
LONG-TERM DEBT OBLIGATIONS (Details Narrative)	Jun. 30, 2024 USD ($)
Debt Instrument [Line Items]
Long term debt, maturity description	mature between 2025 through 2029
Intrest rate	9.50%
First Promissory Note [Member]
Debt Instrument [Line Items]
Principal amount	$ 2,000,000
Intrest rate	7.00%
Outstanding balance	$ 1,713,505
Second Promissory Note [Member]
Debt Instrument [Line Items]
Principal amount	$ 2,035,250
Intrest rate	8.25%
Outstanding balance	$ 1,227,331
Minimum [Member]
Debt Instrument [Line Items]
Long term debt, interest rates	3.69%
Maximum [Member]
Debt Instrument [Line Items]
Long term debt, interest rates	9.95%

MAJOR CUSTOMER AND CONCENTRATION OF CREDIT RISK (Details Narrative) - Customer Concentration Risk [Member]	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Revenue Benchmark [Member] \| Two Largest Customers [Member]
Concentration Risk [Line Items]
Concentration risk percentage	92.00%		89.00%
Revenue Benchmark [Member] \| Largest Customers [Member]
Concentration Risk [Line Items]
Concentration risk percentage		94.00%		92.00%
Accounts Receivable [Member] \| Largest Customer [Member]
Concentration Risk [Line Items]
Concentration risk percentage			99.00%		70.00%

SCHEDULE OF BASIC AND DILUTED EARNINGS PER SHARE (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Earnings Per Share [Abstract]
Net (loss)/income	$ (1,225,681)	$ 36,762	$ (2,439,521)	$ (190,098)
Weighted average shares of common stock outstanding - Basic	101,552,586	80,519,745	101,288,035	79,324,917
Earnings Per Share - Basic	$ (0.01)	$ 0.00	$ (0.02)	$ (0.00)
Unvested Restricted Stock Awards
Weighted average shares of common stock - Diluted	101,552,586	80,519,745	101,288,035	79,324,917
Earnings Per Share - Diluted	$ (0.01)	$ 0.00	$ (0.02)	$ (0.00)

SCHEDULE OF FINANCIAL INFORMATION OF REPORTABLE SEGMENT (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Segment Reporting Information [Line Items]
Sales	$ 2,349,738	$ 3,998,267	$ 6,259,631	$ 7,013,154
Gross profit	(148,929)	845,101	(130,075)	1,494,103
Net income (loss)	(1,225,681)	36,762	(2,439,521)	(190,098)
Assets	19,441,520	9,715,480	19,441,520	9,715,480	$ 23,788,144
Depreciation	638,437	341,726	1,276,872	695,910
Interest expense	165,660	64,997	340,918	108,634
Tax expense	56,600		56,600
Capital expenditures for long-lived assets		38,289		784,515
Range Reclaim [Member]
Segment Reporting Information [Line Items]
Sales	2,050,958	3,882,492	3,556,941	6,870,979
Gross profit	(252,848)	789,687	(832,531)	1,428,266
Net income (loss)	(579,928)	433,922	(1,626,300)	620,565
Assets	12,966,495	9,440,020	12,966,495	9,440,020
Depreciation	634,906	338,409	1,269,811	691,165
Interest expense	61,195	63,061	154,173	105,811
Tax expense
Capital expenditures for long-lived assets		38,289		716,491
Range Minerals [Member]
Segment Reporting Information [Line Items]
Sales	138,118		2,120,233
Gross profit	20,842		357,654
Net income (loss)	(84,121)		152,455
Assets	4,453,028		4,453,028
Depreciation
Interest expense
Capital expenditures for long-lived assets
Range Water [Member]
Segment Reporting Information [Line Items]
Sales
Gross profit
Net income (loss)	(5,154)	(19,116)	(38,736)	(38,280)
Assets	12,579	15,138	12,579	15,138
Depreciation	639	426	1,279	426
Interest expense
Tax expense
Capital expenditures for long-lived assets				15,350
Range Security [Member]
Segment Reporting Information [Line Items]
Sales	160,662	115,775	582,457	142,175
Gross profit	83,077	55,414	344,802	65,837
Net income (loss)	57,302	37,550	289,542	20,445
Assets	226,846	94,610	226,846	94,610
Depreciation	2,892	2,891	5,782	4,319
Interest expense		224		224
Tax expense
Capital expenditures for long-lived assets				52,674
Range Land [Member]
Segment Reporting Information [Line Items]
Sales
Gross profit
Net income (loss)
Assets	1,008,940		1,008,940
Depreciation
Interest expense
Tax expense
Capital expenditures for long-lived assets
Graphium Biosciences [Member]
Segment Reporting Information [Line Items]
Sales
Gross profit
Net income (loss)	(157,275)	(107,444)	(288,915)	(213,621)
Assets	9,147	8,784	9,147	8,784
Depreciation
Interest expense
Tax expense
Capital expenditures for long-lived assets
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Sales
Gross profit
Net income (loss)	(456,505)	(308,150)	(927,567)	(579,207)
Assets	764,485	156,928	764,485	156,928
Depreciation
Interest expense	104,465	1,712	186,745	2,599
Tax expense	56,600		56,600
Capital expenditures for long-lived assets

SEGMENT INFORMATION (Details Narrative)	6 Months Ended
SEGMENT INFORMATION (Details Narrative)	Jun. 30, 2024 Segment
Segment Reporting [Abstract]
Number of reportable segments	6

Malachite Innovations (PK) (USOTC:MLCT)
Historical Stock Chart
From Jul 2024 to Aug 2024

Click Here for more Malachite Innovations (PK) Charts.

Malachite Innovations (PK) (USOTC:MLCT)
Historical Stock Chart
From Aug 2023 to Aug 2024

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

MLCT Malachite Innovations Inc (PK)

Latest MLCT Messages

Loading Messages....

Malachite Innovations Inc (PK) News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

MLCT Malachite Innovations Inc (PK)

Latest MLCT Messages

Loading Messages....

Malachite Innovations Inc (PK) News

Loading Messages....

Your Recent History

Company

Business

Popular

Get The App